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DJ-1 is a multifunctional ubiquitously expressed protein encoded by the PARK7 gene in 
humans. Dysfunction of DJ-1 is implicated in various human diseases, particularly 
neurodegenerative diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD). 
The highly conserved cysteine residue at position 106 has been shown to be an important site 
for posttranslational modifications modulating the activity and localization of DJ-1, and acting 
as a sensor of oxidative and nitrosative stress in the cell. The potential neuroprotective role of 
astroglial DJ-1 as a regulator of antioxidant gene expression and as an antioxidant itself has 
been demonstrated in vitro and in multiple animal models exposed to oxidative stressors. To 
further our understanding of DJ-1’s protective role in astroglia and the importance of the 
conserved C106, we developed a mutant zebrafish line with astroglia-restricted expression of 
DJ-1C106A driven by the promotor region of the glial fibrillary acidic protein (GFAP) (park7
-/-
,Tg(gfap:egfp-2A-flag-zDJ-1C106A)) (UiB2003). The response of UiB2003 larvae to the PD 
phenotype-inducing mitochondrial complex I inhibitor rotenone was compared to that of wild 
type, DJ-1 knockout (DJ-1 KO) and a corresponding astroglial-restricted DJ-1WT-expressing 
zebrafish line (park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1)) (UiB2001). Both UiB2003 and UiB2001 
larvae displayed a drastically lower survival than WT and DJ-1 KO, as well as lowered heart 
rate compared to controls. The UiB2003 larvae also showed significantly higher incidence of 
edema than DJ-1 KOs. The expression of tyrosine hydroxylase (TH), a marker for dopaminergic 
cell death, was reduced in UiB2003 larvae compared to WT under basal conditions. The line 
did however sow a lower induction of inducible nitric oxide synthase (iNOS), a marker for 
intracellular stress, than DJ-1 KO larvae where marker was significantly increased. Adult 
UiB2003 fish showed a reduced complex I activity in skeletal muscle compared to WT fish, 
while the activity in the astroglia-rich brain was unaffected, indicating C106 independent effect 
of DJ-1 on complex I regulation. 
In order to examine the role of cysteine 106 on the ultrastructural localization of DJ-1 in 
response to oxidative stress, fusion proteins of DJ-1WT/DJ-1C106A and the peroxidase APEX2 
were used to facilitate the targeted diaminobenzidine-staining of the SH-SY5Y neuroblastoma 
cells following treatment with rotenone. This produced a DJ-1 specific staining pattern that 
could be visualized by transmission electron microscopy and revealed a mainly cytosolic 
expression of DJ-1, with no staining in the mitochondrial interior, possibly with some faint 
expression at the outer mitochondrial membrane. Additionally, the overexpression of the DJ-




compared to non-transfected cells. Both the localization pattern and induced ER-mitochondria 
contact was independent of the C106 and of rotenone-induced oxidative stress. 
In conclusion, the astroglia-restricted expression of DJ-1C106A, does not protect zebrafish larvae 
from rotenone-induced oxidative insult and even displays a negative effect under baseline 
conditions. On the contrary, it appears to facilitate a stronger negative response and heightened 
sensitivity to the toxicant. On the other hand, DJ-1C106A retains its ability to regulate complex I 
in adult fish and iNOS in larvae. The C106 mutation does not affect the intracellular localization 





















1.1 Parkinson’s disease  
Parkinson’s disease (PD) is among the most common neurodegenerative human diseases, 
afflicting around 1% of people above age 60 (de Lau and Breteler, 2006). It is a progressive 
disorder clinically characterised by tremors, bradykinesia (slowed movement) and postural 
instability. The hallmark of PD is the loss of dopaminergic neurons in the substantia nigra (SN) 
of the mid brain, leading to reduced dopamine levels in the striatum, and the formation of 
abnormal protein aggregates in the neurons known as Lewy bodies (Twelves et al., 2003). The 
ethology and pathogenesis of PD is not fully understood, however oxidative stress, protein 
aggregation and mitochondrial dysfunction is thought to play a major role (Greenamyre and 
Hastings, 2004). 
PD manifests as two distinct forms: sporadic and familial. While the familial form accounts 
only for about 10% of disease cases, the majority of advances made in understanding the 
underlying mechanism of PD and elucidating the pathways and proteins involved have been 
achieved by studying this form. Some notable genes found to lead to PD when mutated are 
park7, α-synuclein, parkin, PTEN-induced punitive kinase 1 (PINK1)   and ubiquitin carboxyl-
terminal hydrolase isozyme L1 (UCHL-1) (Bonifati et al., 2003, Dawson and Dawson, 2003). 
The same gene products are believed to be involved in the pathogenesis of sporadic forms of 
PD, dysregulated due to environmental effects.   
Loss of function mutations in the Park7 gene encoding DJ-1 has been linked to autosomal 
recessive early-onset Parkinson’s disease (Bonifati et al., 2003). The involvement of DJ-1 in 
the initial stress response of PD is supported by elevated levels of DJ-1 found in the brains of 
PD patients, particularly in the astrocytes (Bandopadhyay et al., 2004), as well as increased 
levels of DJ-1 in other neurodegenerative disorders such as Alzheimer’s disease, Pick’s disease, 
progressive supranuclear palsy and multiple sclerosis (Neumann et al., 2004, van Horssen et 
al., 2010). Furthermore, DJ-1 has been found to be highly oxidatively modified in post mortem 
samples of PD patients and to colocalize with pathogenic tau inclusions in multiple 





1.2.1 The DJ-1 protein  
DJ-1 is a small (189 amino acids) protein deglycase encoded by the PARK7 gene. The protein 
is ubiquitously expressed and highly conserved (Bonifati et al., 2003). DJ-1 adopts a helix-
strand-helix sandwich structure and has been found to form a homodimer based on 
crystallographic studies (Honbou et al., 2003, Wilson et al., 2003). Of particular interest in this 
regard is the discovery of a loss-of-function mutant variant of DJ-1 where a highly conserved 
alpha-helical leucine residue is substituted for a proline. This L166P mutant has been found to 
cause a hereditary form of PD (Bonifati et al., 2003). Following this discovery other PD 
causative mutations such as M26I, L10P, and P158∆ have also been found to impair 
dimerization in vitro (Repici et al., 2013). The inability to dimerize is thought to be the direct 
cause of dysfunction, making dimerization crucial for the activity of DJ-1.  
DJ-1is found mainly in the cytoplasm under basal conditions, with a small pool inhabiting the 
nucleus and associated with the mitochondria. It has been suggested that the mitochondrial and 
nucleic localization of DJ-1 can change upon oxidative insult leading to stepwise translocation 
into the mitochondria and then the nucleus (Junn et al., 2009). Conversely, one study based on 
subcellular fractionation found DJ-1 to localize to the mitochondria in untreated SH-SY5Y cells 
(Zhang et al., 2018). Others have found mitochondrial localization to be dependent on oxidative 
stressors (Canet-Aviles et al., 2004, Junn et al., 2009) or a result of nutrient deprivation (Cali et 
al., 2015). There are also conflicting results for the sub-mitochondrial localization of DJ-1. 
Outer membrane-only, inter membrane space and matrix-restricted or matrix has been proposed 







Fig. 1.1 Human DJ-1 monomer. Cartoon representation of the human DJ-1 monomer with 
α-helices shown in red, β-strands in blue and loops in grey. The cysteine at position 106 is 
shown in yellow and can be seen in the active seat of the protein.  
 
1.2.2 The many functions of DJ-1 
DJ-1 is a multifunctional protein and has over the years been found involved in a myriad of 
different pathways and cellular functions. It was first discovered by Nagakubo et al. as a novel 
oncogene product able to transform mouse NIH3T3 cells in a ras-dependent manner (Nagakubo 
et al., 1997). As a protein and nucleotide deglycase, DJ-1 acts in countering the spontaneous 
glycation of macromolecules in the cell. Proteins that are non-enzymatically deactivated by the 
addition of methylglyoxal and glyoxal to cysteine, arginine, and lysine residues, can be returned 
to their functional state by DJ-1-mediated repair (Richarme et al., 2015). DJ-1 is also involved 
in the regulation of multiple pathways in signal transduction. Among these are positive 
regulation of proliferation and survival via activation of the phosphatidylinositol-3-kinase 
(PI3K)/Akt pathway and extracellular signal-regulated kinase (ERK1/2) pathway. It acts anti-
apoptotic through inhibition of apoptosis signal regulating kinase 1 (ASK1) as well as mitogen-
activated protein kinase kinase kinase 1 (MAP3K1), both parts of the apoptosis signalling 
cascade (Oh and Mouradian, 2017).  Another function is in male fertility. A DJ-1 homolog in 
rat, CAP1, was found to decrease in sperm corelating with decreasing fertility, while DJ-1 




2010).  Additionally, DJ-1 has been found to act as a positive regulator of the androgen receptor 
(AR) by binding to the AR-binding transcriptional regulator PIASxα (Takahashi et al., 2001). 
Many of the DJ-1 activities relate to defence against oxidative stress. In addition to acting as an 
antioxidant in itself, scavenging H2O2 by oxidation of cysteine 106, DJ-1 is able to induce 
expression of antioxidant genes of the glutathione and thioredoxin pathways (Andres-Mateos 
et al., 2007, Raninga et al., 2017). Nuclear factor erythroid 2-related factor 2 (Nrf2) has an 
overarching role in the regulation of these genes through the Nrf2/ARE pathway and DJ-1 has 
been shown to act upstream of this regulator (Clements et al., 2006). Furthermore, DJ-1 acts as 
a chaperone on α-synuclein, the main component of Lewy bodies, preventing aggregation 
(Shendelman et al., 2004). DJ-1 is also involved in protein turnover and has been found to 
regulate the 20s proteasome (Moscovitz et al., 2015). DJ-1 is central in maintaining the correct 
morphology and function of mitochondria, additionally affecting autophagy of dysfunctional 
mitochondria, as shown by loss of DJ-1 leading to dysregulation of these activities (Krebiehl et 
al., 2010). In the context of PD and this thesis, DJ-1’s role in the defence against oxidative 
stress, maintenance of mitochondrial function and overall neuroprotection will be in focus. 
1.2.3 Post-translational modifications regulate the functions of DJ-1 
DJ-1 is subject to a variety of posttranslational modifications, notably oxidation, SUMOylation, 
phosphorylation, nitrosylation and gluthationylation (Ariga et al., 2013, Raninga et al., 2017). 
These have different roles in the many functions of DJ-1. SUMO-1 conjugation at lysine 130 
has been shown to be important for DJ-1 mediated cell growth, anti-apoptosis activity in UV-
induced apoptosis but also for ras-dependent transformation, with K130 mutation abrogating 
these functions (Shinbo et al., 2006). DJ-1 has also been found to be subject to p53-dependent 
phosphorylation. The functional role of DJ-1 phosphorylation is largely unknown, but it has 
been suggested that it may play a role in regulating the anti-apoptotic functions of the protein 
(Rahman-Roblick et al., 2008). Glutahionylation of DJ-1 at C53 and C106 has been shown to 
be involved in targeting DJ-1 for degradation in vitro and in vivo (Johnson et al., 2016). This is 
further supported by the observation that loss of glutaredoxin1, the main deglutathionylating 
enzyme in cells, leads to loss of DJ-1 (Saeed et al., 2010). 
Oxidation is thought to be the central player in DJ-1 activity modulation. DJ-1 has been found 
to adopt multiple oxidation states resulting in a pI shift that can be observed by two-dimensional 
gel electrophoresis. A meta-analysis of DJ-1 two-dimensional electrophoresis profiles found 




neurodegeneration (Natale et al., 2010). A similar acid shift is observed after cysteine oxidation 
induced by oxidative stress (Bandopadhyay et al., 2004). DJ-1 was found to have potential sites 
of oxidation on three highly conserved cysteine residues; C46, C53 and C106. Based on 
mutational analyses of these sites, C106 was found to be the most important site of oxidative 
modification and the major player in the acidic pI shift observed under oxidative stress (Canet-
Aviles et al., 2004).  
The conserved C106 of DJ-1 is thought to be fundamental for normal function of the protein. It 
lies within a solvent-accessible cleft at the DJ-1 dimer interface, likely to be the active site 
(Canet-Aviles et al., 2004). Cysteine 106 in is believed to act as an oxidative stress sensor, 
modulating the protein’s activity through reversible stepwise oxidation (Fig 1.2) (Raninga et 
al., 2017). As oxidative stress levels increase the DJ-1 C106 sulfhydryl is first oxidised to the 
low activity sulfenic acid form, and then further to the most active sulfinic acid form as reactive 
oxygen species (ROS) level increases. Further oxidation causes irreversible transition to the 
inactive sulfonic acid form. The C106 residue can also be S-nitrosylated, enabling DJ-1 to act 
in transnitrosylation-based regulation of the phosphatase and tensin homolog (PTEN), a key 
player in neuronal cell death (Choi et al., 2014). 
 
Fig. 1.2 Post-translational modifications of DJ-1 cysteine 106. A: The activity of DJ-1 is 
modulated through stepwise oxidation of cysteine 106. The transition to the low activity 
sulfenic acid form and further to the most active sulfinic acid form is reversible, while 
oxidation to the sulfonic acid form is irreversible and renders DJ-1 inactive. B: In addition to 
oxidation, the Cys106 can undergo S-nitrosylation and transfer the nitrosyl group as part of 





1.2.4 DJ-1 in relation to mitochondrial function 
As briefly mentioned in section 1.2.2, DJ-1 plays an integral role in regulating mitochondrial 
homeostasis. DJ-1 has been shown to play an important role in regulation of mitochondrial 
function and activity with DJ-1 deficiency leading to change in mitochondrial membrane 
potential, altered morphology, i.e. fragmentation and loss of connectivity, and impaired 
respiration (Krebiehl et al., 2010, McCoy and Cookson, 2011). Mitochondrial dysfunction has 
been demonstrated to be age-related and particularly prominent in high energy-demanding 
tissues in both DJ-1 KO Drosophila and mice (Hao et al., 2010). Oxidation of cysteine 106 to 
the sulfinic acid form is proposed to be required for DJ-1 to exerts its impact/effect on 
mitochondria. This has been shown by a DJ-1 mutant unable to form the sulfinic acid form due 
to alterations to the active site being unable to counter mitochondrial fragmentation despite the 
presence of C106 (Blackinton et al., 2009). A similar disruption of mitochondrial dynamic is 
seen with loss of DJ-1, causing increased fragmentation, lowered membrane potential and 
autophagy (McCoy and Cookson, 2011). Loss of DJ-1 has been shown to affect autophagy in 
mouse and human cells (Krebiehl et al., 2010). A similar effect was seen in lymphoblasts 
obtained from familial PD patients belonging to the families where PARK7 was first identified. 
Here the PD samples had more fragmented mitochondria as well as altered autophagic activity 
(Irrcher et al., 2010). The DJ-1 mediated regulation of autophagy has been found to involve 
multiple pathways, notably the ERK and Akt pathways (Oh and Mouradian, 2017). 
Endoplasmic reticulum-mitochondria tethering is also affected by DJ-1. Loss of DJ-1 causes 
reduced contact and reduced Ca2+ uptake in the mitochondria. DJ-1 is important for 
mitochondrial Ca2+ homeostasis by facilitating uptake of Ca2+ from ER to the mitochondria via 
specific contact sites (Ottolini et al., 2013). 
DJ-1 regulates the activity of complex I of the electron transport chain (ETC) and has been 
found to bind the complex I subunits ND1 and NDUFS4, promoting stability (Hayashi et al., 
2009). DJ-1 deficient cells have also been found to have impaired complex I assembly and 
supercomplex formation (Heo et al., 2012). Both knockdown and dysfunctional variants of DJ-
1 has been reported to result in reduced complex I activity (Hayashi et al., 2009, Zhang et al., 
2018). Interestingly, reduced complex I activity has also been linked to the pathogenesis of PD. 
Both the activity and amount of complex I has been found to be reduced in post-mortem 




1.2.5 Neuroprotective function of astrocytic DJ-1 
Astrocytes are highly abundant glia cells and constitute up to 90% of cells in the human brain 
depending on the region (Park et al., 2012). Not all organisms have the characteristic star-
shaped astrocytes found in humans, but nonetheless they still possess cells that serve a 
corresponding function. The astrocytes play an important role in maintaining redox homeostasis 
in neurons (Jimenez-Blasco et al., 2015). Reactive oxygen species and nitrogen species 
(ROS/RNS) are by-products of cellular respiration via the electron transport chain in 
mitochondria. At moderate levels they play important roles in signalling and regulatory 
pathways in the cell but at increased levels ROS/RNS may cause damage by oxidising proteins, 
lipids or DNA (Mailloux et al., 2013). Neurons are especially susceptible to such damage due 
to their inability to renew themselves, a high basal mitochondrial activity and high lipid content 
(Salim, 2017).  
DJ-1 is found in low levels in neurons, but high levels in astrocytes, and astrocytic DJ-1 appears 
to play an important role in protecting neurons from oxidative stress (Bandopadhyay et al., 
2004). It has been shown that neurons co-cultured with astrocytes have improved survival 
compared to neuronal monocultures when treated with ROS-inducing stressors (Mullett and 
Hinkle, 2009). Culturing neurons with astrocyte-conditioned media had a similar protective 
effect. When neurons were co-cultured with DJ-1 deficient astrocytes however, they were not 
protected against the ROS-induced cell death, linking the protective effect to astrocytic DJ-1 
expression. Frøyset et al. showed that zebrafish with increased astrocytic DJ-1 expression were 
more resistant to oxidative stressors compared to wild type animals, supporting the redox-
regulating role of DJ-1 also in vivo (Froyset et al., 2018).  
Increased levels of DJ-1 has been found to regulate astrocyte-mediated protection of neurons 
through different pathways. This includes activation of the antioxidant master regulator Nrf2. 
By DJ-1 binding to the Nrf2 inhibitor Keap1, Nrf2 is free to translocate from the cytosol into 
the nucleus (Clements et al., 2006). Here Nrf2 binds antioxidant response elements (ARE), 
facilitating transcription of the associated genes, which include members of the glutathione 
pathway such as glutamate cysteine ligase (GCL) and glutathione synthase (GSS), and redox 
regulating enzymes such as thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1) and superoxide 
dismutase 1 (SOD1) (Espinosa-Diez et al., 2015). DJ-1 is also involved in the clearance of 
excess glutamate from the extracellular space and uptake into the astrocytes via regulation of 
the channel EAAT2. This prevents glutamate-induced toxicity thus protecting the neurons (Kim 




positive regulation of the Nrf2/Keap1 pathway resulting in upregulation of antioxidant genes 
and increase in extracellular GSH levels. In this way the antioxidant activity from the astrocytes 
can match the needs of the neurons as increased neuronal activity leads to increased secretion 
of glutamate (Habas et al., 2013). Furthermore, DJ-1 has been shown to reduce the activity of 
induced nitric oxide synthase (iNOS) presumably via inhibition of ASK1 during oxidative 
stress, thereby preventing excess formation of nitric oxide (NO). At high levels NO may lead 
to impaired protein function through excessive S-nitrosylation as can be seen in 
neurodegenerative disorders (Waak et al., 2009). We have summarized the neuroprotective 
function of astrocyte DJ-1 in Figure 1.3. 
The dopaminergic neurons of the substantia nigra are particularly sensitive to oxidative stress 
due to heightened base level mitochondrial oxidative stress (Surmeier et al., 2017) and ROS 
production being a natural part of dopamine metabolism (Mouradian, 2002). These neurons 
may therefore be especially dependant on DJ-1 activity despite the levels of DJ-1 in the neurons 
themselves being relatively low. This sensitivity could explain the selective neurodegeneration 
seen in PD patients with loss of function DJ-1.  
 
Fig. 1.3 The neuroprotective role of astrocytic DJ-1 under conditions of oxidative stress. 
Astrocytic DJ-1 acts in a transcellular manner via multiple pathways to reduce oxidative 
stress in neurons. (1) DJ-1 inhibits iNOS-mediated production of NO via inhibition of ASK1. 
(2) Increased transcription of antioxidant genes and oxidative stress response genes via 
activation of the master regulator Nrf2. (3) Increased astrocytic glutamate uptake leading to 
activation of the Nrf2/ARE pathway and reduced glutamate-mediated cell toxicity. From 




1.3 Neurotoxicant-based models of Parkinson’s disease 
An important part of research into the underlying mechanisms that lead to PD are the many 
neurotoxicant-based models of sporadic Parkinson’s disease that have emerged over the years. 
1-methyl-4-phenylpyridinium ion (MPP+), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
(MPTP), Paraquat, 6-hydroxydopamine (6-OHDA) and rotenone have all been used to model 
aspects of PD pathogenesis such as the loss of dopaminergic neurons, formation of Lewy bodies 
and movement dysfunction (Zeng et al., 2018). Although exerted through different modes of 
action, the common effect of these neurotoxicants is an increase in the intracellular levels of 
oxidative stress that eventually leads to the PD-characteristic loss of dopaminergic neurons. 
Rotenone is a lipophilic compound naturally found in plants of the Derris and Lonchocarpus 
genus. It has previously been used extensively as a pesticide and piscicide, but the use has since 
been discontinued in many countries due to its high toxicity, feared environmental impact and 
ability to induce parkinsonian phenotypes (Heinz et al., 2017). 
Rotenone acts on cellular respiration via irreversible inhibition of complex I of the electron 
transport chain (ETC). By occupying the Co-enzyme Q (CoQ) binding site on Complex I, 
rotenone effectively prevents binding of CoQ and transport of electrons further down the ETC. 
This does however not prevent the normal transferring of electrons from NADH into Complex 
I. With transfer to CoQ blocked, electrons are instead transferred to O2 in the matrix, forming 
the initial mitochondrial ROS superoxide (O2
•−) (Murphy, 2009). This block in the ETC also 
leads to reduced production of ATP. Elevated levels of ROS may lead to oxidative damage, 
lipid peroxidation, defective proteins and DNA damage, and further down the line, 
mitochondrial dysfunction and apoptosis (Greenamyre and Hastings, 2004). 
It is this elevated ROS production that causes the PD-like state. As previously stated, the 
dopaminergic neurons of the SN are particularly sensitive to oxidative stress (Mouradian, 2002, 
Surmeier et al., 2017) and increased oxidative stress has been linked to both neurodegeneration 








Fig. 1.4 The molecular structure of rotenone  
 
 
1.4 Zebrafish as a model organism for Parkinson’s disease 
The zebrafish (Danio rerio), a small tropical freshwater fish, is emerging as a popular model 
organism for human disease. They are convenient animals in that they are easy to house, have 
a relatively short generation time of approx. 2-3 months and readily reproduce in captivity. 
Furthermore, a single female may produce up to hundreds of offspring per mating. The external 
fertilisation makes controlling mating and developmental conditions, as well as experimental 
treatment of the eggs, far easier than using many other models. Development is rapid with most 
vital organs formed already 24 hours post fertilization. The eggs themselves and the early 
embryos are transparent, and embryos/larvae readily take up compounds from the water around 
them (Santoriello and Zon, 2012). Zebrafish embryos are thus particularly ideal for drug 
screening, as changes to the developing organs are readily observable in the transparent body 
(Parng et al., 2002).  
In addition to the more practical aspects of using zebrafish as a model organism, there is a high 
degree of conservation of genome organisation, developmental course as well as signal 
transduction pathways between zebrafish and humans (Best and Alderton, 2008). It has been 
estimated that approximately 80% of human disease-related genes have corresponding 
orthologs in zebrafish (Howe et al., 2013). The overall organisation of the zebrafish brain, as 




Sive, 2003). Additionally, many of the major neurotransmitter systems, e.g. dopaminergic and 
noradrenergic, are present (Rink and Wullimann, 2004).  
Of particular interest in the context of PD is the ventral diencephalic cluster in zebrafish, 
seemingly homologous to the midbrain in mammals where the substantia nigra is located (Son 
et al., 2003). The zebrafish homolog of the dopaminergic neuronal marker protein tyrosine 
hydroxylase (TH), which constitutes the rate limiting step in dopamine synthesis, is also found 
in the neurons of this area (Holzschuh et al., 2001). As previously stated in section 1.1, it is the 
loss of dopaminergic neurons in the substantia nigra that is the hallmark of PD. Parkinsonian 
effects such as impaired movement, oxidative stress, mitochondrial dysfunction, selective 
dopaminergic neurodegeneration and loss of TH has been demonstrated using neurotoxin-
induced zebrafish models and genetic/knockdown models (Xi et al., 2011). 
1.5 Zebrafish transgenesis via the I-SceI meganuclease system 
Mutational analysis using genetically modified animal models overexpressing disease-related 
genes, expressing mutated variants of these genes or with complete knockouts, have given 
further insight into their function (Grunwald and Eisen, 2002). The external fertilization, high 
number of eggs per mating as well as the translucent eggs and embryos make zebrafish ideal 
animal models for studies based on transgenesis, as microinjections can be performed directly 
on the egg at the one-cell stage and effects can be observed from this point.  
Classical transgenesis, i.e. injecting zebrafish with a transgene-harbouring plasmid only, 
generally yields a low expression rate. The transgene may initially be expressed at the early 
stages of development, but not incorporated in the genome so that expression is eventually lost. 
In the case that the transgene is incorporated, this is often in a mosaic pattern with low germline 
transmission, so that positive F0 fish only yield a few percent positive offspring. Transgenesis 
in fish has been greatly improved using the I-SceI enzyme. By co-injecting plasmids harbouring 
a transgene flanked by the I-SceI recognition site with the I-SceI enzyme at the 1-cell stage both 
the number of positive F0 fish and the germline transmission is vastly improved, with up to 
50% of the F1 generation inheriting the transgene, as well as reduced mosaicism (Thermes et 
al., 2002).  
I-SceI is a meganuclease originally isolated from the yeast Saccharomyces cerevisiae with an 
18 bp recognition site. Due to the large recognition site, this sequence is expected to occur 
randomly only once in 7×1010 bp and does not occur in the zebrafish genome (Thermes et al., 




understood, put is thought to involve I-SceI causing a double-stranded break in the genome. I-
SceI was initially used to study homologues recombination, but it’s ability to induce a double 
strand break is likely nonspecific as insertion has been observed at independent sites. By 
continuously cutting the plasmids at the recognition site, I-SceI counteracts the endogenous 
ligase activity of the cell, leaving the insert to be integrated via the endogenous repair machinery 
(Grabher et al., 2004). While other methods such as Tol2 are more prone to multiple insertion 
events, I-SceI favours single insertions (Grabher et al., 2004).  
1.6 The APEX2 system for ultrastructural protein localization  
A newly developed tool for ultrastructural protein localization and proteomics is the peroxidase 
APEX2. It is a 27 kDa modified form of soybean APX with the introduced mutations K14D, 
W41F, E112K and A134P. These modifications have shown to improve the catalytic properties 
of APX, further improving its use in electron microscopy and proteomics (Lam et al., 2015). 
APEX2 catalyses the polymerisation of 3,3’-diaminobenzidine (DAB) in the presence of 
hydrogen peroxide, forming an insoluble precipitate. This activity is retained in fixed cells and 
useful for staining as the polymer cannot diffuse and remains at the original site of formation. 
The polymer is visible by bright-field microscopy. Furthermore, it can be rendered EM-visible 
by osmium tetroxide treatment as this compound reacts with the DAB polymer, leaving 
electron-dense osmium (Martell et al., 2017). By engineering fusion constructs of APEX2 and 
a protein of interest, connected by a flexible linker, the DAB polymer will be distributed in the 
cell based on the distribution of this protein. This method has previously been demonstrated 
with the electron microscopy-based determination of the sub-mitochondrial localization pattern 
of MICU1, a regulatory protein involved in calcium uptake (Lam et al., 2015). APEX2 can also 
be used to catalyse the biotinylation of proximal endogenous proteins in live cells. This in 
combination with streptavidin-based chromatography followed by mass spectrometry makes 
APEX2 fusion proteins useful tools for proximity-based protein mapping (Hung et al., 2016). 
1.7 Background and aims of the study 
To further our understanding of PD ethology and pathogenesis and the role of DJ-1, two 
genetically modified zebrafish lines have already been established and characterised in our lab. 
The first line, UiB1001 (Tg(gfap:egfp-2A-flag-zDJ-1)), is a Tübingen AB (TAB) line with 
astroglial-specific overexpression of DJ-1 driven by elements of the glial fibrillary acidic 
protein (GFAP) promotor (Froyset et al., 2018). Larvae of this line were found to be protected 
against MPP+-induced damage related to oxidative stress, demonstrating the protective role of 




of astrocytes overexpressing DJ-1 showed an upregulation of proteins involved in redox 
regulation, mitochondrial respiration and inflammation.  
The second line, UiB2000 (park7-/-), is a TAB-based line with complete knockout of DJ-1 
(Edson et al., 2019). This line did not display any phenotype at the larval or young adult stage. 
Older fish however, showed a lowered expression of tyrosine hydroxylase, downregulated 
mitochondrial complex I activity and a visual phenotype of low body weight and decreased 
pigmentation, especially in males. Through label-free mass spectrometry of adult brain samples 
the impact on protein expression was examined. Five main groups of proteins with changed 
expression compared to wild types were found in the DJ-1 KO fish; protein involved in stress 
response and vesicle trafficking, the mitochondrial transport chain, glutathione metabolism, 
inflammation and translational regulation. 
Using the already established DJ-1 KO zebrafish line (UiB2000), a line with astroglial-
restricted expression of DJ-1 has been established to see if this had a similar protective effect 
as seen in the astroglial overexpression line UiB1001. Following this we wanted to create a 
corresponding astroglial-specific DJ-1C106A line to investigate whether the effects of astroglia-
restricted expression of DJ-1 were dependent on the C106 residue, i.e. if this line would 
resemble the KO line or if any of the protective effects of the UiB1001 line would be exhibited. 
In addition to developing and characterising the astroglial-specific DJ-1C106A zebrafish line, we 
wanted to determine the ultrastructural localization of WT DJ-1 and the C106A mutant in vitro, 
and to look for changes in the localization pattern of these two variants in response to rotenone-
induced oxidative stress. This would be done first by creating APEX2-linked DJ-1WT/C106A 
fusion constructs and then using SH-SY5Y cells as an in vitro model of neuronal cells in which 
the fusion constructs could be expressed. The localization pattern of the fusion proteins would 
then be determined by transmission electron microscopy. The potentially redox-sensitive 
mitochondrial localization was of particular interest as the results from different studies highly 
are conflicting. Previous results are mainly based on subcellular fractionation and fluorescence 







In summary, the principle goal of this thesis was to understand the function of the C106 
residue of DJ-1 in oxidative stress response. Our objectives were therefore to: 
• Create an astroglial-restricted DJ-1C106A expressing zebrafish line from the established 
DJ-1KO line. 
• Characterise the new line and compare it to the WT, DJ-1 KO and UiB2001 lines in 
terms of both basal and stress-induced damage and alterations in protein expression. 
• Generate a hDJ-1WT-APEX2 and hDJ-1C106A-APEX2 plasmid constructs. 
• Use APEX2 constructs to visualise the ultrastructural localisation pattern of DJ-1WT 




















2.1 Plasmid constructs 
Plasmid Supplier (Cat. No.) 
DsRed2-Mito-7 Addgene (55838) 
pcDNA3 APEX2-NES Addgene (49386) 
pcDNA3 Flag-DJ-1WT-APEX2-NES - 


















E16-DJ Seq 2 CATGGTCCTGCTGGAGTTC DNA sequencing/ 
PCR screening 









H04_hDJ1-APEX2_F GTAACAACTCCGCCCCATTG DNA sequencing 
H05_hDJ1-APEX2_R GGTGCTTGATGGTTCCGAAG DNA sequencing 
 
2.3 Enzymes 
Name Type Restriction site (5’-3’) Supplier (Cat. No.) 








TAGGGATAA|CAGGGTAAT New England 
Biolabs (R0694S) 
KpnI Restriction GGTAC|C New England 
Biolabs (R0142S) 
NcoI Restriction C|CATGG New England 
Biolabs (R0193S) 
NotI-HF Restriction   






N/A New England 
Biolabs (M0371S) 
T4 DNA Ligase DNA Ligase N/A New England 
Biolabs (M0202S) 









2.4 Readymade buffers and media 
Name  Supplier (Cat. No.) 
CutSmart® Buffer New England Biolabs (B7204S) 
10x DNA Loading Buffer Takara (9157) 
NativePAGE Running Buffer (20X)       ThermoFisher scientific 
(BN2001) 
NativePAGE Sample Buffer (4X) ThermoFisher scientific 
(BN2003) 
NEBuffer™ I-SceI (10x) New England Biolabs (B0694) 
NEBuffer™ 1 (10x) New England Biolabs (B7001S) 
dNTP mix PCR grade Roche (11 814 362 001) 
Dulbecco’s Modified Eagle’s Medium - high glucose 
(DMEM) 
Sigma-Aldrich (D6429) 





NuPAGE® Transfer Buffer (20X) Thermo Fisher Scientific 
(NP0006-1) 
10x PfuUltra II reaction buffer Agilent Technologies (600670) 
S.O.C. Medium Thermo Fischer Scientific 
(15544034) 
T4 DNA Ligase Reaction Buffer New England Biolabs (B0202S) 
 
2.5 Commercial gels and membranes   
Name  Supplier (Cat. No.) 
Amersham™ Hybond™ P 0.45 PVDF Blotting 
Membrane 
GE Healthcare Life science 
(10600023) 
NativePAGE™ 3-12% Bis-Tris Protein Gel Thermo Fisher Scientific 
(BN1001BOX) 
NuPAGE® 4-12% Bis-Tris Protein Gel Thermo Fisher Scientific 
(NP0321BOX) 
 
2.6 Molecular size markers 
Name Use Supplier (Cat. No.) 
NativeMark Unstained 
Protein Standard 
Native PAGE protein 
standard 
Thermo Fisher Scientific 
(LC0725) 
PageRuler Plus Prestained 
Protein Ladder 
Western blot protein size 
marker 
Thermo Fisher Scientific 
(26619) 
Quick-Load® Purple 2-Log 
DNA Ladder 
Agarose gel DNA size 
marker 
New England Biolabs 
(N0550S) 
 
2.7 Bacterial strains 
Name Use Supplier (Cat. No.) 
Escherichia coli Subcloning 








2.8 Cell lines 
Cell line Derived from Supplier 
SH-SY5Y Human bone marrow neuroblastoma ATCC 
 
2.9 Antibodies 
Antibody Dilution Description Supplier (Cat. No.) 
Primary  Clonality, Host  
Anti-DJ-1 1:3000 Polyclonal, Rabbit Novous Biological (NB300-270) 
Anti-TH 1:10 000 Monoclonal, Mouse ImmunoStar (22941) 
Anti-iNOS 1:2000 Monoclonal, Mouse BD Biosciences (610431) 
Secondary  Clonality, Host, Conjugate  
Anti-Rabbit 1:10 000 Polyclonal, Donkey, HRP Jackson ImmunoResearch  
(711-035-152) 
Anti-Mouse 1:10 000 Monoclonal, Donkey, HRP Jackson ImmunoResearch  
(715-035-150) 
 




UiB1001 TAB Tg(gfap:egfp-2A-flag-zDJ-1) 
UiB2000 TAB park7-/- 
UiB2001 UiB2000 park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1) 
UiB2003 UiB2000 park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1C106A) 
Spotty wild type (SWT) - - 
Tübingen AB (TAB) - - 
 
2.11 Commercial kits 
Name Use Supplier (Cat. No.) 
BigDye Terminator v3.1 Cycle 
Sequencing Kit 











QIAquick® Gel Extraction Kit DNA extraction from 
agarose gel 
Qiagen (28706) 
QIAquick® PCR Purification Kit DNA purification from 
PCR 
Qiagen (28106) 




2.12 Chemicals and reagents 
Chemical Supplier (Cat. No.) 
Acetic acid 100%  Merck KGaA (100063) 
Agar 100 Resin Agar scientific Limited (R1031) 
Ampicillin sodium salt Sigma-Aldrich (A0166-5G) 
β-Nicotinamide adenine dinucleotide, reduced 
disodium salt hydrate 
Sigma-Aldrich (N8129-100MG) 
Bovine Serum Albumin (BSA) Sigma-Aldrich (A7906) 
Bromophenol blue Sigma-Aldrich (B0126-25G) 
Calcium chloride dihydrate Merck KGaA (1.02382.1000) 
CHAPS Sigma-Aldrich (C3023) 
3,3’-Diaminobenzidine Sigma-Aldrich (D8001-1G) 
Digitonin (5%) ThermoFisher scientific (BN2006) 
Dimethylarsinic acid sodium salt trihydrate Merck KGaA (8.20670.0100) 
Dimethyl sulphoxide (DMSO) Sigma-Aldrich (D2438) 
DL-Dithiothreitol (DTT), min 99% titration Sigma-Aldrich (D0632) 
EDTA Merck KGaA (108431) 
Ethanol VWR (20821.330) 
Ethyl 3-aminobenzoate methanesulfonate salt Sigma-Aldrich (A5040) 
Gelatine capsules Electron Microscopy Sciences (70103) 
Glutaraldehyde 25% solution Chemi-Teknikk AS (16310) 
Glycerine 87%, AnalaR NORMAPUR® 
analytical reagent 
VWR (24385.295) 




HCl, 37% Merk KGaA (100317) 
Hepes  Merck (110110) 
K2HPO4 Sigma-Aldrich (P3786) 
KH2PO4  Merck KGaA (104873) 
KCl  Merck (104936) 
LB Broth Sigma-Aldrich (L3022-1KG) 
LB Broth with agar (Lennox) Sigma-Aldrich (L2897-1KG) 
Lead (II) nitrate Merck KGaA (1.07398.0100) 
Methanol VWR (20847.307) 
Methylene blue Merck KGaA (159270.0100) 
MgSO4  Sigma-Aldrich (M7506) 
NaCl  VWR (27810.295) 
NaF, SigmaUltra min. 99%  Sigma-Aldrich (S7920) 
Na3VO4, min. 90% titration   Sigma-Aldrich (S6508) 
Nancy-520 Sigma-Aldrich (01494-500UL) 
NativePAGE™ 5% G-250 Sample Additive Thermo Fisher Scientific (BN2004) 
Nitro Blue Tetrazolium chloride, 98+% Alfa Aesar (J60230) 
Osmium tetraoxide Electron Microscopy Sciences (19134) 
Paraformaldehyde Sigma-Aldrich (P6148) 
Phenol red  Sigma-Aldrich (P5530) 
PonceauS Sigma-Aldrich (P3504) 
Protease inhibitor cocktail (tablets) complete 
mini  
Roche (118361530012) 
Rotenone MP Biomedicals (150154) 
Sodium n-dodecyl sulfate (SDS), 20% aq. 
soln. 
Alfa Aesar (J63394) 
Sucrose  Sigma-Aldrich (84100) 
SuperSignal™ West Pico PLUS 
Chemiluminescent Substrate 
Thermo Fischer Scientific (34577) 
Tri-natriumcitrat di-hydrate Merck KGaA (567446-1) 
Trizma base (H2NC(CH2OH)3) Sigma-Aldrich (T1503) 
Trypsin/EDTA (0.05%/0.02% w/v) Biochrome (L2153) 




Uranylacetate Electron Microscopy Sciences (22400) 
 
2.13 Instruments 
Name Use Manufacturer  
Beckman GS-15R Centrifuge Centrifugation Beckman Coulter 
BIOFUGE pico Centrifugation Heraeus 
ChemiDoc™ XRS+ Imaging 
System 
Western blot visualisation  Bio-Rad 
DNAEngine PTC-200 rev Polymerase chain reaction, 
Restriction digestion 
Bio-Rad 
Electrophoresis power supply - 
EPS 301 
Power supply Amersham Biosciences 
GelDoc™ EZ imager DNA gel visualisation  Bio-Rad 
LEICA M420 Macroscope Zebrafish larvae imaging Leica 





Nanodrop ND-1000™ DNA and protein 
concentration 
measurements 
Thermo Fisher Scientific 




Thermo Fisher Scientific 




Thermo Fisher Scientific 
Picospritzer III-Intracellular 
microinjection dispense system 
Zebrafish egg injection Parker 
SteREO Lumar. V12 Fluorescent 
microscope 
eGFP screening Zeiss 
Reichert Ultracut S 
Ultramicrotome 
Ultrathin sectioning Leica 











SDS-PAGE, Native PAGE Thermo Fisher Scientific 
Hoefer SE 260 system SDS-PAGE Hoefer Inc 
Eppendorf 5810 centrifuge  Eppendorf 
 
2.14 Software and online tools 
Name Use Developer 
EMBOSS Needle DNA pairwise sequence alignment EMBL-EBI 
Fiji Protein quantification LOCI 
CLC Main Workbench DNA sequencing data viewer Qiagen Bioinformatics 
Codon Usage in Homo 
sapiens 
Codon optimization Codon Usage Database 
 
2.15 Buffers, media and solutions 
All buffers, media and solutions are prepared with Milli-Q ultrapure water unless otherwise 
specified. 
2.15.1 Cultivating bacteria 
1x LB-Agar 
35g/L LB Broth with agar  
(Autoclaved) 
 
1x LB medium 
35g/L LB Broth 
(Autoclaved) 
Ampicillin stock (100µg/mL) 
100 µg/mL Ampicillin sodium salt 
 
 
2.15.2 Mammalian cell culturing and experimental treatment 
DMEM complete 
10% (v/v) Fetal Bovine Serum 





10x PBS (pH 7.4) 
1.55 M NaCl  
58 mM Na2HPO4 • 2H2O  
18 mM KH2PO4  





1x Trypsin solution 
0.01% (w/v) Trypsin 
0.004% (w/v) EDTA 
in 1x PBS (pH 7.4) 
 
 
Na-Cacodylate buffer (pH 7.4) 
0.2 M Dimethylarsinic acid sodium salt 
trihydrate 
0.2 M Sucrose 
0.005 M Calciumchlorid-dihydrat 
2x Cacodylate buffer (pH 7.4) 
4 mM CaCl2 · 2H2O 
in 0.2 M Na-Cacodylate buffer 
 
2 % Glutaraldehyde fixation solution 
2% (vol/vol) Glutaraldehyde 
in 1x Cacodylate buffer 
Glycine quenching solution 
20 mM Glycine 
in 1x Cacodylate buffer 
 
10x DAB solution 
5 mg/mL Diaminobenzidine  
in 0.1 M HCl 
1x DAB staining solution 
1x DAB solution 
10 µM H2O2 
1x Cacodylate buffer 
 
 
2.15.3 Agarose gel electrophoresis 
50x TAE 
242 g/L Trizma base 
50 mM EDTA 
57.1 mL/L Glacial acetic acid 
 
 
2.15.4 SDS-PAGE and western blotting 
5x SDS sample buffer 
250 mM Tris (pH 6.8) 
10 % (w/v) SDS 
50 % (v/v) Glycerol 
0.025 % (w/v) Bromophenol blue 
0.5 M DTT 
 
10x TG 
250 mM Trizma base 




1x TGS (Running buffer) 
1x TG 
0.1% (v/v) SDS 
 
1x TG + methanol (Transfer buffer) 
1x TG 
10% (v/v) Methanol 
 
Ponceau S solution 
0.1% (w/v) Ponceau S  






2.15.5 Zebrafish embryo and larvae growth, maintenance and experimental 
treatment  
1x E3 Blank  




1x E3 Blue 




0.01 % (v/v) Methylene blue 
 
10x Injection buffer 
0.1 M KCl 
0.5% (w/v) phenol red 
Injection gel 
1.5 % (w/v) agarose  
in 1x E3 Blank 
 
Tricaine stock solution (pH 7.0) 
4 mg/ml Ethyl 3-aminobenzoate 
methanesulfonate salt 
21 mM Tris (pH 9) 
 
Tricaine (for euthanasia) 
6 ml Tricaine stock solution 
in 100 ml fish water 
10x PE (pH 7.6) 
100 mM K2HPO4  
100 mM KH2PO4  
10 mM EDTA 
 
Homogenization buffer 
1x PE buffer  
6 mg/mL CHAPS 
50 mM NaF 
200 μM NaVO4 




2.15.5 Complex I in-gel activity assay  
Complex I homogenization buffer 
3mM EDTA  
250 mM Sucrose  
100mM Hepes (pH 7.5) 
Complex I substrate solution 
2mM Tris-HCl (pH 7.4)  
0.1 mg/ml NADH  























3.1.1 T4 DNA ligation 
Reactions were prepared with 1x T4 DNA Ligase Reaction Buffer, 100 ng vector, the amount 
of insert that would yield a 1:3 molar ratio of vector to insert and 1 µL of T4 DNA Ligase to a 
final of volume of 20 µL. If a higher insert to vector ratio was used this is specified. The 
reactions were incubated at 16°C O/N. 
3.1.2 Heat shock transformation of DH5α bacteria, colony growth and plasmid 
isolation 
50 µl of DH5α cells were thawed on ice for 10 min before gently adding 1-3 µl of ligation 
reaction or plasmid. Cells were incubated on ice for 30 min, heat shocked for 40 secs in a 42 
°C water bath and then immediately put on ice for 2 min. 200 µl of S.O.C. medium was added 
to the cells before incubating at 37 °C and 250 rpm for 1 hour. 50 and 100 µl of each bacterial 
preculture were plated on separate LB-Agar plates containing 100 µl/ml ampicillin and 
incubated at 37 °C O/N.  
Colonies were picked from the plates and used to inoculate 4 ml of medium (LB, 100 µg/µl 
ampicillin) in 15 ml tubes. Tubes were incubated at 37 °C and 250 rpm O/N. A bacteria-free 
control was prepared and incubated accordingly.  
The bacterial O/N cultures were pelleted by centrifugation at 10 000 rpm for 3 min and the 
supernatant was removed. Plasmid was extracted using the QIAquick® Spin Miniprep Kit 
following the supplier’s manual. The nucleic acid concentration of the plasmid preps was 
determined using the Nanodrop ND-1000™, with appropriate sample buffer as blank. All 
following determination of nucleic acid concentration was done accordingly. 
3.1.3 DNA sequencing  
DNA sequencing was done using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems). Samples were prepared using 1 µl BigDye, 1 µl BigDye Buffer, 200 ng template 
DNA, and 3.2 pmol of the appropriate forward or reverse sequencing primer, to a final volume 








The cycle sequencing was then run on a thermal cycler using the following program: 
Step Temp Time  
Initial denaturation 96 °C 1 min  
     Denaturation 96 °C 10 sec  
     Annealing 50 °C* 5 sec 25 cycles  
     Extension 60 °C 4 min 
Final extension - -  
Hold 4 °C ∞  
 
* The standard annealing temperature 50 °C was used unless a sequencing primer-specific annealing 
temperature (5 °C below primer Tm) is specified  
After the PCR was completed, 10 µl of Milli-Q was added to each sample and the samples 
delivered to the University of Bergen DNA Sequencing Lab for sequencing. 
3.1.4 Agarose gel electrophoresis 
To visualise DNA, determine the size of and to isolate specific fragments, DNA-containing 
samples were prepared and separated on an agarose gel. Gels were prepared by dissolving 1% 
(w/v) agarose in 1x TAE Buffer by repeated boiling in a microwave oven. When the liquid gel 
mix cooled to 60 °C, 1 µL Nancy-520 was added per 50 mL gel solution and the gel casted in 
an Owl™ EasyCast™ B1 or B2 Mini Gel Electrophoresis System. Samples were prepared with 
1x DNA Loading Buffer (Takara) and run in the Owl™ EasyCast™ B1 or B2 Mini Gel 
Electrophoresis System with 1x TAE as running buffer at 90-100V until adequate separation. 
Samples containing 1x Green GoTaq® Buffer were loaded directly onto the gel without adding 
additional loading buffer. Visualization and imaging were done using the GelDoc™ EZ imager. 
3.1.5 Zebrafish care 
Adult Zebrafish, larvae and eggs/embryos were kept at the University in Bergen Zebrafish 
facility following facility guidelines. 
Zebrafish mating for experiments or line maintenance was done by keeping the males and 
females separated O/N in specialized mesh partition boxes. The fish were combined in the top 
portion of the box the following morning, allowing eggs to collect below the mesh. Eggs were 
collected with a net and kept in E3 Blue in 10 cm petri dishes in a 28 °C incubator. Eggs to be 
screened by fluorescence were kept in E3 Blank to avoid background fluorescence.  
Adult zebrafish screened negative or to be used for collecting brain and muscle samples were 




movement ceased, the fish was placed in a <4°C ice slush for 20 min and then stored at -20°C. 
Brain and muscle samples were harvested prior to freezing as needed. 
 
3.2 Establishment of the transgenic zebrafish line (UiB2003) 
3.2.1 Site-directed mutagenesis: introducing DJ-1 Cys106 to Ala106 mutation to 
the pBs-ISceI-gfap:eGFP-2A-Flag-zDJ-1 plasmid vector 
Mutagenesis and subsequent DpnI-digestion were performed using the QuickChangeII Site-
Directed Mutagenesis Kit. 1x reaction buffer, 50ng pBs-ISceI-gfap:eGFP-2A-Flag-zDJ-1 
plasmid (Froyset et al., 2018), 125ng of each of the primers E11-DJ106 Fw and E12-DJ106 
Rev (see section 2.2), 1 µl PCR grade dNTP mix and 2.5 U PfuUltraII DNA polymerase was 
prepared to a final volume of 50 µl. A template-free PCR control was prepared accordingly. 
The reaction was run on a DNAEngine PTC-200 rev thermal cycler using the following 
program: 
Step Temp Time  
Initial denaturation 95 °C 30 sec  
     Denaturation 95 °C 30 sec  
     Annealing 55 °C 1 min 30 cycles  
     Extension 68 °C 13 min 
Final extension - -  
Hold 4 °C ∞  
 
Both the zDJ-1 Cys106 to Ala106 mutation PCR sample and the control plasmid PCR sample 
were then incubated with 10 U DpnI for 1 hr at 37 °C in the thermal cycler. 
The DpnI-digested mutated plasmid pBS-ISceI-gfap:eGFP-2A-Flag-zDJ-1C106A PCR was used 
to transform DH5α cells. Bacterial cultures were grown from the resulting pBS-ISceI-
gfap:eGFP-2A-Flag-zDJ-1C106A-transformed colonies and plasmid samples subsequently 
prepped from each culture as described in section 3.1.2. 
3.2.2 DNA sequencing: Verifying the DJ-1 Cys106 to Ala106 mutation in the 
pBs-ISceI-gfap:eGFP-2A-Flag-zDJ-1C106A plasmid vector 
In order to verify the newly introduced C106A point mutation in the zDJ-1 gene of the pBs-
ISceI-gfap:eGFP-2A-Flag-zDJ-1C106A plasmid vector, the zDJ-1 region of the plasmid was 




forward sequencing primer E16-DJ Seq 2 (see table 2.2) and the primer-specific annealing 
temperature 57°C.  
3.2.3 Double digestion of the pBS-ISceI-GFAP:eGFP-2A-Flag-zDJ-1WT and 
pBS-ISceI-GFAP:eGFP-2A-Flag-zDJ-1C106A plasmids and reinsertion of zDJ-
1C106A into the original vector 
The mutated plasmid harbouring zDJ-1C106A verified by sequencing and the original zDJ-1WT-
harbouring plasmid were double digested. For each plasmid, both a 500 ng and 1000 ng plasmid 
sample were prepared. Samples were prepared with 1x NEBuffer 1, 1x BSA, 500 ng or 1000 
ng of plasmid, 2 U KpnI (NEB) and 2 U NcoI (NEB) to a final volume of 20 µL. Digestion was 
run at 37°C for 1 h. 
In order to isolate the desired plasmid fragments, the samples were run on a 1% agarose gel 
(see section 3.1.4) at 90V for 55 min. 1.5 µg 2-Log NEB ladder was used as standard. The 
resulting 10500 bp band of the original plasmid and the 1580 bp band of the zDJ-1C106A plasmid 
were excised from the gel and purified using the QIAquick Gel Extraction Kit (Qiagen) 
according to the manufacturers protocol.  
The plasmid fragments were ligated using T4 ligation (see section 3.1.1) and the resulting 
ligation mix used to transform DH5α cells. Heat shock transformation and subsequent colony 
growth and plasmid miniprep was performed as previously described (see section 3.1.2). 
3.2.4 Verifying the insertion of zDJ-1C106A in the pBS-ISceI-GFAP:eGFP-2A-
Flag- zDJ-1C106A plasmid by PCR screening 
The correct reinsertion of the zDJ-1C106A-harbouring fragment in the plasmid was verified by 
PCR screening using primers whose ca. 1000 bp amplicon span the insert-plasmid reinsertion 
site. Samples were prepared with 1 µL of the newly prepared pBS-ISceI-GFAP:eGFP-2A-Flag-
zDJ-1C106A miniprep or 1 µL of a 1:10 dilution of the same miniprep, 1x Green GoTaq
® 
Reaction Buffer, 1.25 mM MgCl2, 0.2 mM dNTP, 0.5 µM of each of the primers E-16 DJ-1 
Seq and H01_zDJ1-C106A_rev (see table 2.2) and 0.5 U of GoTaq® DNA Polymerase to a final 
volume of 20 µL. Corresponding samples with the original pBS-ISceI-GFAP:eGFP-2A-Flag-







The reaction was run on a DNAEngine PTC-200 rev thermal cycler using the following 
program: 
Step Temp Time  
Initial denaturation 95 °C 5 sec  
     Denaturation 95 °C 35 sec  
     Annealing 56 °C 40 sec 30 cycles  
     Extension 72 °C 1.5 min 
Final extension 72 °C 5 min  
Hold 4 °C ∞  
 
Samples were subsequently run on a 1% agarose gel with 1 µg 2-Log NEB ladder as standard 
at 90V for 1 hour and subsequently imaged (see section 3.1.4). 
3.2.5 Injecting DJ-1 KO zebrafish eggs with the pBS-ISceI-GFAP:eGFP-2A-
Flag-zDJ-1C106A plasmid for ISceI-based transgenesis to produce the new mutant 
line 
DJ-1 KO fish (park7-/-) (REF-manuscript) were set up as described in section 3.1.5 to obtain 
eggs. An injection mix was prepared from 100 ng of pBS-ISceI-GFAP:eGFP-2A-Flag-zDJ-
1C106A plasmid, 1x NEBuffer™ I-SceI, 1 µL I-SceI and 1 µL injection buffer to a final volume 
of 10 µL and loaded into a glass capillary microinjection needle that was then mounted on a 
Picospritzer III-Intracellular microinjection dispense system. Fertilized eggs were collected and 
immobilized in the grooves of an injection gel, and immediately injected directly into the 
cytoplasm at the 1-cell stage with ca. 1.8 nL of the injection mix. Successfully injected eggs 
were incubated in E3 Blank at 28 °C until screening. 
3.2.6 Screening injected embryos for eGFP expression 
Following injection, the larvae were screened for enhanced green fluorescent protein (eGFP) 
expression at 2dpf using a Lumar Zeizz fluorescence microscope. Larvae displaying clear 
fluorescence in the head, eyes and along the spine were counted as positive, while larvae 
displaying no fluorescence, only vague fluorescence in the yolk sac or throughout the body, or 
single patches of fluorescence were counted as negative. Both mosaic and uniform expression 




3.2.7 Screening the adult F0 UiB2003 fish by mating with Spotty WT and 
continuing the line  
At 3-4 months old the adult F0 fish were screened by individually mating each fish with Spotty 
WT fish and subsequently screening the progeny for fluorescence as described in the previous 
section. Adult fish producing 10-50% positive embryos were combined as the UiB2003 F0 
generation. The UiB2003 F0 fish were then outcrossed with UiB2000 (park7-/-) fish, the 
progeny was screened for fluorescence and positive larvae grown to adulthood. Adult F1 fish 
were again screened by Spotty WT-mating as previously described. The resulting heterozygous 
UiB2003 F1 fish were incrossed to yield F2 offspring which were screened for positives at 1 
dpf or 2 dpf and used for rotenone experiments or for continuing the line.  
3.3 Characterizing the UiB2003 zebrafish line 
3.3.1 Effect of rotenone-induced oxidative stress  
At 2 dpf, embryos were manually dechorinated using syringe needles and treated at 48 hpf with 
either 30 nM rotenone or 1.4 ⋅10-4% (v/v) DMSO as control. For a single dose-response 
experiment, groups were treated with 20 nM, 30 nM, 40 nM rotenone or DMSO control. After 
24 hours of exposure, the survival and number of larvae afflicted by pericardial and yolk sac 
edema were determined. Heart rates were measured using a mechanical counter by counting the 
heart beats over 15 sec for 8 larvae per treatment group. Larvae were imaged at this point using 
a LEICA M420 Macroscope or harvested for whole larvae protein lysates. 
3.3.2 Preparation of zebrafish whole larvae protein lysates by sonication 
Larvae were resuspended in 150 µL homogenization buffer and sonicated on ice at 30% 
amplitude, pulse at 1 sec on/1 sec off, for an effective sonication time of 4x5 sec using a 
VibraCell VCX130, 130 W ultrasonic processor with a 2 mm sonication probe. Samples were 
incubated on ice for 15 min, subsequently centrifuged at 16000x g, 4 °C for 10 min, and the 
supernatant then collected as the final protein lysate. The protein concentration was determined 
using the Nanodrop ND-1000™ according to the manufacturer’s protocol. 
3.3.3 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
To separate proteins from zebrafish whole larvae lysates, samples were prepared with 40 µg 
protein, 1x SDS sample buffer and Milli-Q to a final volume of 20 µL. The samples were 
incubated at 95 °C for 5 min and loaded onto either a premade gel or homemade gel. Premade 
NuPAGE® 4-12% Bis-Tris gels were used to obtain good separation of high kDa target proteins 




If homemade gels were used these were prepared as 1 mm thick 10% polyacrylamide running 
gels using 375 mM Tris-HCl (pH 8.8), 0.1% SDS, 10% acrylamide, 0.05% (w/v) APS, 0.08% 
(v/v) TEMED and Milli-Q to a final volume of 6 mL. The gel was immediately casted in the 
Hoefer SE 260 system and isopropanol layered on top to smooth out the gel border. A 4% 
stacking gel solution was prepared using 125 mM Tris-HCl (pH 6.8), 0.1% SDS, 4% 
acrylamide, 0.1% (w/v) APS, 0.16% (v/v) TEMED and Milli-Q to a final volume of 3 mL, and 
immediately casted onto the solidified running gel after removing the isopropanol. Samples 
were prepared as described above and run on homemade gels in the Hoefer SE 260 system 
using 1x Running Buffer and run at 20 mA with runtime depending on the kDa of the proteins 
to be visualised.  
3.3.4 Western blotting 
A PVDF blotting membrane was primed briefly in methanol, rinsed in deionised water and then 
kept submerged in blotting buffer until use. NuPAGE® Transfer Buffer was used for premade 
gels and homemade blotting buffer for homemade gels. Blotting was run at 14V, 4°C O/N in a 
XCell II™ Blot Module using the aforementioned buffers.  
Following blotting, membranes were incubated with Ponceau S for 5 min, rinsed in deionized 
water and subsequently imaged using the ChemiDoc™ XRS+ Imaging System. Membranes to 
be probed with anti-DJ-1 were then incubated in 2x blocking solution, while membranes to be 
probed with anti-iNOS or anti-TH were incubated in 1x blocking solution. Membranes were 
subsequently incubated with primary antibody; anti-DJ-1 in 1% blocking solution for 1 hr at 
RT, anti-iNOS or anti-TH in 0.5% blocking solution at 4 °C O/N. Membranes were then washed 
4 x 5 min in PBS-T and incubated with secondary antibody, anti-rabbit for DJ-1 and anti-mouse 
for iNOS or TH, for 1 hr at RT in 0.5% blocking solution. Membranes were again washed 4 x 
5 min in PBS-T. Imaging was done using the ChemiDoc™ XRS+ Imaging System after coating 
the membranes in freshly mixed SuperSignal™ West Pico PLUS Chemiluminescent Substrate. 
3.3.5 Complex I in-gel activity assay 
Brain and muscle samples were harvested from male adult TAB and UiB2003 F1 fish (see 
section 3.1.5). Muscle samples were collected from single fish while three brains were 
combined for each brain sample. 150 µL complex I homogenization buffer was added to each 
sample and the samples homogenized by 80x punches with an Eppendorf pellet pestle. 
Additional 150 µL complex I homogenization buffer were added, and the samples centrifuged 
at 600x g for 10 min at 4 °C. The supernatant was collected as total lysate and subsequently 




resuspended in 150 µL homogenization buffer before centrifuged at 7000x g for 10 min at 4 
°C. The supernatant was again discarded, and the pellet resuspended in 30 µL homogenization 
buffer to obtain the mitochondrial fraction lysate. The protein concentration was determined 
using the Nanodrop ND-1000™. 
Lysate samples were prepared using 21 µg protein, 1x NativePAGE Sample Buffer and 0.2% 
Digitonin and subsequently incubated on ice for 20 min followed by centrifugation at 15 000x 
g for 15 min at 4 °C. The supernatant was collected, and 0.25% G-250 Sample Additive added 
for a final sample volume of 25 µL. The samples were run on a NativePAGE™ 3-12% Bis-Tris 
Protein Gel in an XCell SureLock™ Electrophoresis Cell with 1x NativePAGE Running Buffer 
on ice for 30 min at 150V followed by 60 min at 250V. NativeMark Unstained Protein Standard 
was used as standard. 
Fresh Complex I substrate solution was prepared, and the gel incubated in this solution for 
approx. 15 min until bands were visible. The reaction was stopped with 10% acetic acid and 
the gel imaged using the ChemiDoc™ XRS+ Imaging System. 
 
3.4 Generating fusion constructs for determination of ultrastructural localization 
of DJ-1 using APEX2. 
3.4.1 Generating hDJ-1WT and hDJ-1C106A inserts for APEX2 plasmid 
In order to prepare the hDJ-1WT and hDJ-1C106A ORFs for insertion into the pcDNA3 APEX2-
NES plasmid the desired modifications to the sequences were generated via PCR. Samples were 
prepared with 1x PfuUltra II reaction buffer, 0.25 mM dNTPs, 100 ng of the respective template 
plasmids harbouring hDJ-1WT and hDJ-1C106A, 0.4 µM of the forward primer 
H02_hDJ1_Bsp120I_F and 0.4 µM of the reverse primer H03_ hDJ1_Bsp120I_R (see section 
2.2) and 1 µL of PfuUltra II Fusion HotStart DNA Polymerase to a final volume of 25 µL. The 
reaction was run on a DNAEngine PTC-200 rev thermal cycler using the following program: 
Step Temp Time  
Initial denaturation 95 °C 2 min  
     Denaturation 95 °C 20 sec  
     Annealing 60 °C 20 sec 30 cycles  
     Extension 72 °C 15 sec 
Final extension 72 °C 3 min  




Samples were subsequently analysed by agarose gel electrophoresis to verify the amplification 
of the desired fragment. A Nancy-520-stained 1% agarose gel was used with 10 µL Quick-
Load® Purple 2-Log DNA Ladder as standard and electrophoresis run at 100V for 1.5 hours 
(see section 3.1.4). An identical PCR was run, and the resulting samples purified using the 
QIAquick® PCR Purification Kit (Qiagen) according to the manufacturers protocol. 
3.4.2 Introducing hDJ-1WT and hDJ-1C106A to the pcDNA3 APEX2-NES plasmid 
by restriction digestion and subsequent DNA ligation  
Digestion reactions were prepared for each of the hDJ-1WT and hDJ-1C106A purified PCR 
products using 1 µg PCR product, 10 mM Tris-HCl buffer (pH 7.55 at 37 °C), 10 mM MgCl2, 
0.1 mg/mL BSA and 10 U Bsp120I to a final volume of 50 µL. Digestions were incubated at 
37 °C for 16 hours and then heat inactivated at 80 °C for 20 min. The digested samples were 
then run on a 1 % agarose gel at 90V for 50 min (see section 3.1.4) and the digested fragments 
excised from the gel and purified using the QIAquick Gel Extraction Kit (Qiagen) according to 
the manufacturers protocol. 
A second digestion mix was prepared with 1x CutSmart® Buffer, 1 µg of pcDNA APEX2-NES 
plasmid and 10 U NotI-HF to a final volume of 50 µL. This reaction was incubated for 15 min 
at 37 °C and then heat inactivated at 65 °C for 20 min. 2.5 U of rSAP was then added to the 
sample and incubated at 37 °C for 30 minutes before heat inactivation at 65 °C for 5 min.  
The Bsp120I-digested hDJ-1WT and hDJ-1C106A inserts were introduced to the NotI-digested 
and dephosphorylated pcDNA3 APEX2-NES plasmid using T4 ligation (se section 3.1.1) with 
an insert to vector molar ratio of 1:6.  
The ligation mix was used to transfect DH5α cells and the subsequent colony and culture growth 
and following miniprep done as previously described (see section 3.1.2). 
3.4.3 Screening minipreps for plasmids with correct insertion by restriction 
analysis 
Each of the pcDNA3 DJ-1WT-APEX2-NES and pcDNA3 DJ-1C106A-APEX2-NES plasmid 
mini preps were analysed by restriction digestion using NdeI. Samples were prepared with 1x 
CutSmart® Buffer, 500-600 ng of plasmid and 5 units of NdeI to a final volume of 25 µL and 
subsequently incubated at 37°C for 40 min.  
The digested samples were loaded onto a 1% agarose gel and run at 90V for approx. 2.5 hour 
and imaged as described in section 3.1.4. 15 µL Quick-Load® Purple 2-Log DNA Ladder was 




3.4.4 Verification of the pcDNA3 DJ-1WT-APEX2-NES and pcDNA3 DJ-1C106A-
APEX2-NES fusion constructs by DNA sequencing 
In order to verify the successful introduction of the hDJ-1WT/C106A genes as well as the correct 
orientation of the genes in the pcDNA3 APEX2-NES plasmid vector, all plasmids screened 
positive or ambiguous via restriction analysis were sequenced as described in section 3.1.3 
using the forward sequencing primer H04_DJ1-APEX2_F and the reverse primer H05_DJ1-
APEX2_R (see table 2.2). 
3.5 Ultrastructural analysis of DJ-1wt and DJ-1C106A cellular localization 
3.5.1 Seeding 
One day prior to transfection a 90-100% confluent 10 cm dish of SH-SY5Y cells was removed 
from the incubator and the medium gently removed by aspiration. The cells were rinsed with 
1x PBS and 1x Trypsin solution added dropwise directly onto the cell layer and the cells 
incubated for approx. 2 min in a 37°C, 5% CO2 incubator until detaching. The trypsination was 
stopped by adding fresh DMEM complete at 10 times the volume of the 1x Trypsin solution 
and the cell suspension was collected. The cells were pelleted by centrifugation at 160 x g for 
5 min, the medium discarded, and the pellet resuspended in 6 mL DMEM complete. To obtain 
70-80 % confluence in each well of a 6-well plate on the following day, 600-700 µL of this cell 
suspension was added to 1.5 mL DMEM complete per well. The appropriate cell suspension 
volume for seeding was determined empirically for each cell batch prior to running the 
experiment.  
3.5.2 Transfection  
24 h after seeding, the cells were co-transfected with 2 µg of pcDNA3 hDJ-1WT-APEX2-NES 
or pcDNA3 hDJ-1C106A-APEX2-NES and 2 µg of DsRed2-Mito-7 using Lipofectamine 1000 
following the manufacturers protocol. The DMEM complete was replaced with antibiotic-free, 
serum-free DMEM prior to adding the transfection complexes and the cells were incubated in 
this transfection medium for 6 h at 37 °C and 5 % CO2 before replacing the medium with 
DMEM complete and continuing the incubation O/N. A non-transfected control was prepared 
accordingly. 
3.5.3 Rotenone treatment 
24 h after transfection the transfection medium was replaced with DMEM complete medium 
containing 250 nM rotenone and 0.0011% (v/v) DMSO or 0.0011% (v/v) DMSO only. Cells 




3.5.4 Fixation and diaminobenzidine-staining 
The cells were removed from the incubator and the cell medium replaced with 800 µL of 37 °C 
prewarmed 2 % glutaraldehyde solution. The glutaraldehyde solution was immediately replaced 
with 1.2 mL fresh 2 % glutaraldehyde solution and the cells placed on ice. All following steps 
were performed on ice. After 60 min of fixation, the glutaraldehyde solution was removed, and 
the cells were washed 5 x 2 min with 2 mL of 1x cacodylate buffer. The buffer was then replaced 
with 2 mL of the 20 nM glycine quenching solution and the cells incubated on ice for 5 min 
and again washed 5 x 2 min with 2 mL of 1x cacodylate buffer. The washing buffer was 
removed and replaced with 3 mL of 1x DAB solution (10 mM H2O2) and the cells incubated 
for ca. 10 min until the DAB reaction product could be visualized by light microscopy. Cells 
were washed 5 x 2 min with 2 mL of 1x cacodylate buffer and subsequently imaged using a 
light microscope. 
3.5.5 Transmission electron microscopy 
To prepare the DAB stained cells for transmission electron microscopy, cells were post fixed 
with 1% osmium tetraoxide in 0.1 M sodium cacodylate buffer for 1 hour. Following post fix 
cells were rinsed twice with 0.1 M sodium cacodylate buffer. The cells were then dehydrated 
by incubation in increasing concentrations of ethanol; 20 min in 35% ethanol, 20 min in 50% 
ethanol, 20 min in 70% ethanol, 20 min in 96% ethanol and finally 3 x 20 min in 100% ethanol. 
All steps up until dehydration with 70% ethanol were done on ice. The cells were then set in a 
1:1 mix of Agar 100 Resin and ethanol for 1 hour at 37 °C. The liquid was removed and 
immediately replaced with a thin layer of 100% Agar 100 Resin and the samples incubated at 
37°C O/N. Gelatine capsules were then pressed into the cell layer and the samples incubated at 
60°C O/N. The capsules were filled with resin and left to polymerise at 60°C for 2 days. The 
capsules were broken off the wells of the 6-well cell plate and the cell monolayer cut into 60 
nm thin sections using a Reichert Ultracut S Ultramicrotome. The sections were subsequently 
stained 20 min with 2% uranylacetat and rinsed in Milli-Q. Lead citrate staining solution was 
prepared as described by Reynolds (Reynolds, 1963) and sections stained for 10 min. Finally, 
imaging was done using a JEM-1230 Transmission Electron Microscope with an integrated 






4.1.1 Verification of site-directed mutagenesis 
In order to create a plasmid vector for generating zebrafish with astroglial over-expression of 
mutant (C106A) DJ-1, a Cys106 to Ala106 mutation was introduced to the DJ-1 ORF of the 
pBs-ISceI-gfap:eGFP-2A-Flag-zDJ-1 plasmid by site-directed mutagenesis (Fig. 4.1). The 
plasmid contains regulatory components of the glial fibrillary acidic protein (GFAP) promotor 
which gives an astroglial-specific expression pattern (Froyset et al., 2018, Bernardos and 
Raymond, 2006).  
 
Fig. 4.1 Sequencing alignment of zDJ-1WT and zDJ-1C106A. The introduction of a C106A 
mutation to the DJ-1 ORF of the pBS-ISceI-gfap:eGFP-2A-Flag-zDJ-1WT plasmid by site-
directed mutagenesis was verified by DNA sequencing. The site of the mutation is indicated 
by an orange box with the wild type variant TGT (Cys) shown in the upper sequence and the 
mutated variant GCT (Ala) shown in the lower sequence.  
 
4.1.2 Generation of zebrafish with astroglial over-expression of DJ-1C106A  
In order to validate successful incorporation of gfap:eGFP-2A-Flag-zDJ-1C106A into the DJ-1 
knock-out line (Edson et al., 2019) larvae were screened for expression of the reporter protein 
eGFP. Due to the viral 2A segment between eGFP and DJ-1C106A, the two proteins are expressed 
in equimolar amounts as two separate proteins. Thus, fluorescence-validated expression of 
eGFP is assumed to correspond to the expression pattern of DJ-1C106A.  
Due to the possibility that F0 fish screened positive at the larval stage are not able to transfer 
the transgene to their offspring, either as a result of mosaicism or temporary expression of 
plasmids not incorporated in the genome at the time of screening, the adult F0 fish were 
screened by Spotty WT mating (Fig. 4.2). The proportion of eGFP-positive embryos produced 




or very low levels of positive offspring (1-5%), indicating mosaic expression of the transgene. 
Only a single male F0 fish produced the 50% positive offspring expected of mendelian single 
gene inheritance from a heterozygous individual. At the F1 generation, however, all screened 
park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1C106A) (UiB2003) fish were positive and displaying the 
expected mendelian inheritance.  
 
Fig. 4.2 Astroglial eGFP expression in park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1C106A) 
(UiB2003) larvae. UiB2003 F1 embryos at 1 dpf (A and C) and 2 dpf (B and D) comparing 
eGFP-positive and negative embryos. The same embryos are imaged with A-B: white light 
and C-D: fluorescence images of 1 dpf (A and C) and 2 dpf (B and D) embryos. Panels shows 
both eGFP positive and negative embryos. The 2 dpf embryos were dechorinated prior to 
imaging. As seen in panel C-D, eGFP expression is found in the head region and spinal cord 






4.1.3 Verification of Flag-tagged DJ-1C106A expression 
Astroglial DJ-1C106A expression in the DJ-1 wild type null background was verified at the 
protein level by Western blotting (Fig. 4.3). The endogenous DJ-1 protein has an expected size 
of approx. 20 kDa, while the size of Flag-tagged DJ-1 is approx. 22 kDa. Figure 4.3 shows that 
UiB2003 expresses Flag-DJ-1 with no endogenous DJ-1 background. The figure also shows 
endogenous DJ-1 and Flag-DJ-1 expression in lysates from Tg(gfap:eGFP-2A-Flag-zDJ-1) 
(UiB1001) and DJ-1 KO (park7-/-) (UiB2000) for comparison. 
UiB2003 had a higher expression of Flag-tagged zDJ-1C106A compared to the Flag-tagged zDJ-
1WT in the UiB1001 larvae. Flag-tagged zDJ-1WT level in isolated astroglial cells from UiB1001 
has previously been shown to be approx. 10-times higher than the endogenous DJ-1 level 
(Frøyset et al., 2018). Thus, it appears that the astroglial zDJ-1C106A level in the UiB2003 larvae 
far exceeds the endogenous DJ-1 in astroglial cells. 
 
 
Figure 4.3 DJ-1 expression in transgenic larvae 
A: Lysates from 3 dpf larvae were separated by SDS-PAGE and analysed by Western blotting 
using a DJ-1 antibody which detects both endogenous and Flag-tagged DJ-1. Expression of 
Flag-tagged DJ-1C106A (approx. 22 kDa), but not endogenous DJ-1 (approx. 20 kDa), was 
observed in the UiB2003 larvae. The astroglial DJ-1 overexpression line UiB1001 was used 
as a reference as it possesses both the endogenous DJ-1 and the Flag-tagged DJ-1. B: Ponceau 






4.2 Sensitivity of transgenic lines to oxidative stress 
4.2.1 Oxidative stress induced changes in gross anatomy and heart rate 
To test if the established transgenic lines had a different tolerance for oxidative stress we 
exposed larvae to the mitochondrial complex I inhibitor rotenone for 24 hrs starting at 2 dpf. 
Larvae from WT, DJ-1 KO (park7-/-) (UiB2000), UiB2001 (park7-/-,Tg(gfap:egfp-2A-flag-zDJ-
1)) and UiB2003 (park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1C106A)) that were exposed to rotenone all 
exhibited pericardial (P.E.) and yolk sac edema (Y.E.) and pronounced development defects as 
e.g. bent spines (Fig. 4.4). These phenotypes were not observed in unexposed larvae (Fig. 4.4 
A, C, E, and G).  
Rotenone also affected survival rates of the embryos (Figure 4.5 A). Interestingly, only larvae 
with astroglial DJ-1WT or mutant DJ-1 showed a significant decrease in survival rate, whereas 
DJ-1 knock-out larvae did not. Additionally, both these two lines showed more pronounced 





Fig. 4.4 Phenotypic defects of rotenone exposure. Dechorinated WT, DJ-1 KO (park7-/-) 
(UiB2000), UiB2001 (park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1)) and UiB2003 (park7-/-
,Tg(gfap:egfp-2A-flag-zDJ-1C106A)) larvae were treated with 30 nM rotenone (B, D, F and H) 
or DMSO control (A, C, E and G) at 2 dpf. Larvae were imaged 24 h after exposure. Defects 
such as pericardial (P.E.) and yolk sac edema (Y.E.), and a bent spine were found within all 
rotenone-treated groups. Examples of these defects are indicated in panel B by arrows. 
DMSO-treated control groups did not display rotenone-induced phenotypes. A scalebar (0.5 






Rotenone decreased the heart rate of the exposed larvae from both wild type and transgenic 
animals (Figure 4.5 C). This effect was less pronounced in DJ-1 knock-out larvae compared to 
wild type and larvae selectively expressing DJ-1 or mutant DJ-1 in astroglia (Figure 4.5 C).  
  
 
Fig. 4.5 Exposure to rotenone at the embryonic stage is detrimental to larval 
development and survival, with severity dependant on DJ-1 expression. Dechorinated 
WT, DJ-1 KO (park7-/-) (UiB2000), UiB2001 (park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1)) and 
UiB2003 (park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1C106A)) larvae were treated with 30 nM 
rotenone or DMSO control at 2 dpf. After 24 h of exposure heart rate (bpm) (A), 
developmental defects in the form of pericardial and yolk sac edema (B), and survival (C) 
was determined. Data on survival and edema is presented as mean percentage (n=2) for 
UiB2001 and rotenone-treated UiB2003, and mean percentage (n=3) + SEM for the 
remaining groups, with data obtained from individual experiments with 15-30 larvae per 
treatment group. Heart rate data is presented as mean bpm (n=16-24) + SEM from the same 
experiments. P values were determined by two-tailed t-Test with p<0.05 (*), p<0.01 (**) and 






4.2.3 Effect of oxidative stress on protein expression in transgenic lines 
Following the determination of heart rate, survival and gross anatomy after rotenone exposure, 
the surviving larvae were harvested and whole larvae lysates prepared and analysed by Western 
blotting (Fig. 4.6). The expression of tyrosine hydroxylase (TH), a marker protein of 
dopaminergic neuronal health, and inducible nitric oxide (iNOS), a marker for intracellular 
oxidative stress, were examined, quantified and normalised to the overall loaded protein amount 
using Ponceau S bands. The nitric oxide synthase antibody used detects three different isoforms 
of NOS; nNOS, eNOS and iNOS. Only the inducible form, iNOS, is addressed in this study 
(indicated by asterisk). Figure 4.6 panel A and B shows representative blots of rotenone effect 
on TH and NOS expression respectively while panel C and D show the corresponding 
quantitation of Western blots probed for these proteins. As seen in Fig. 4.6 panel C, the WT 
larvae showed a markedly lower TH level in rotenone-treated larvae compared to controls 
(p<0.01) while the same effect could not be seen for DJ-1 KO, UiB2001 or UiB2003 larvae. 
DMSO-treated UiB2003 larvae however, showed significantly lower (p<0.05) TH levels 
compared to DMSO-treated WT larvae. In the case of iNOS expression (panel D), an elevated 
level was observed in rotenone-treated DJ-1 KO larvae compared to the treated WT larvae 
(p<0.05). Rotenone-treated UiB2003 larvae on the other hand had a significantly lower iNOS 





Fig. 4.6 Effect of rotenone exposure on tyrosine hydroxylase and inducible nitric oxide 
synthase. WT, DJ-1 KO (park7-/-) (UiB2000), UiB2001 (park7-/-,Tg(gfap:egfp-2A-flag-zDJ-
1)) and UiB2003 (park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1C106A)) larvae were exposed to 30 nM 
rotenone or vehicle from 2 to 3 dpf. Protein lysates from whole larvae were separated by 
SDS-PAGE and analysed by Western blotting using antibodies towards tyrosine hydroxylase 
(TH) and nitric oxide synthetase (NOS). The latter detects nNOS, eNOS, and iNOS (indicated 
by asterisk). Panel A and B show representative blots of TH and NOS respectively, in which 
Ponceau-S is used as loading control. Panel C and D show quantitation of Western blots 
probed with anti-tyrosine hydroxylase (C) and anti-nitric oxide synthase (D) in which 
Ponceau S staining was used as a loading control. Data are the mean (n=2) for UiB2001 and 
rotenone-treated UiB2003, and mean (n=3) + SEM for the remaining groups, of three 
individual experiments with 15-30 larvae per treatment group. P values were determined by 











4.2.4 Rotenone dose-response of transgenic lines 
As 30 nM rotenone resulted in increased larvae deaths a dose-response experiment was 
performed. Larvae were exposed for to 20 nM, 30 nM or 40 nM rotenone or vehicle for 24 hrs 
starting at 2 dpf and the survival rate and edema determined (Fig. 4.7). Both WT and DJ-1 KO 
larvae showed a similar response with no death or edema at the lowest concentration, moderate 
edema rate but no death at 30 nM rotenone and high edema rate but low death at 40 nM. The 
UiB2003 larvae seemed to be more sensitive to rotenone. At 20 nM rotenone 100% of larvae 
were afflicted by edema and at 30 nM the majority of the larvae were dead. At 40 nM none of 
the UiB2003 larvae survived. All control groups were unaffected with a 100% survival rate. 
 
 
Fig. 4.7 Preliminary dose-response experiment shows UiB2003 larvae to be more 
sensitive to rotenone than both WT and DJ-1 KO larvae WT, DJ-1 KO (park7-/-) 
(UiB2000) and UiB2003 (park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1C106A)) zebrafish embryos 
were treated at 2 dpf with 20, 30, or 40 nM of rotenone or with DMSO as negative control. 
After 24 hrs of treatment the survival rate and number of larvae displaying pericardial and 
yolk sac edema was determined. Each bar represents the percentage of survival in a group 
after exposure to the indicated treatment, while the dark portion of each bar represents the 
percentage of the live larvae afflicted by pericardial and yolk sac edema within this group. 









4.2.5 Effect of astroglial-restricted DJ-1C106A on Complex I activity 
DJ-1 has been shown to regulate the activity of mitochondrial complex I of the electron 
transport chain. Whether this regulation is dependent of C106 oxidation of DJ-1 is not known. 
To investigate if the complex I activity of UiB2003 fish was affected by the astroglial-restricted 
expression of DJ-1C106A, total lysates and mitochondrial fraction lysates from adult WT and 
UiB2003 fish were separated by native page and complex I activity analysed by an in-gel 
complex I activity assay (Fig. 4.8). Figure 4.8 shows that complex I activity appears in several 
bands in the native gel. The bands represent both complex I alone and in supercomplexes with 
mitochondrial complex III, and IV. The lack of endogenous DJ-1 in skeletal muscle of UiB2003 
reduced mitochondrial complex I activity as compared to control animals. Mitochondria 
isolated from UiB2003 brains with astroglial DJ-1 expression on the other hand seemed to 
maintain its complex I activity.  
 
 
Fig. 4.8 Complex I activity in skeletal muscle and brain of WT and UiB2003 fish. A: 
Adult WT and UiB2003 (park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1C106A)) fish were euthanised 
and brain and skeletal muscle were harvested. Muscle samples were collected from single 
fish while three brains per line were combined for the brain for further mitochondria isolation. 
Extract total lysates (TOTAL) and mitochondrial fraction lysates (MITO) were analysed by 
native PAGE followed and in-gel mitochondrial complex I activity assay.  B: Supercomplex 








4.3 Intracellular localization of WT and mutant DJ-1 in oxidative-stressed cells 
4.3.1 Verification of functional DJ-1-APEX2 expression in SH-SH5Y cells 
The fusion protein plasmids, pcDNA3 Flag-DJ-1WT-APEX2-NES and pcDNA3 Flag-DJ-
1C106A-APEX2-NES were verified by sequencing and used to transiently transfect SH-SY5Y 
cells. Cells were exposed for 24 h to 250 nM rotenone or vehicle starting the day after 
transfection. Cells were then fixed and stained with diaminobenzidine (DAB) (Fig. 4.9). DAB 
staining could be detected by low magnification (10x) light microscopy and was observed as 
light brown coloration in the cytoplasm. The transfection efficiency was ca. 20-30% in all 
transfected samples (panel A, B, C and D) regardless of DJ-1-APEX2 variant and treatment 
(data not shown). No staining was observed in the non-transfected DAB-stained control (Fig. 







Fig. 4.9 Diaminobenzidine staining in transfected SH-SY5Y cells visualised by light 
microscopy SH-SY5Y cells were transfected with pcDNA3 hDJ-1WT-APEX2-NES (panel A 
and B), pcDNA3 hDJ-1C106A-APEX2-NES (panel C and D) or non-transfected as control 
(panel E), and after 24 h exposed to 250 nM rotenone (panel B and D) or to DMSO (panel 
A, C and E) for 24 hours before fixation and diaminobenzidine staining. DAB staining was 
visualised by light microscopy. Examples of DAB-stained cells are indicated in panel A, B, 





4.3.2 Ultrastructural determination of WT DJ-1 and mutant DJ-1 localization 
There is conflicting evidence as to whether the cysteine in position 106 of DJ-1 is necessary for 
the mitochondrial localization of DJ-1 in response to oxidative stress or not (Canet-Aviles et 
al., 2004, Junn et al., 2009). The intramitochondrial localization of the DJ-1 has been proposed 
as outer membrane-restricted and conversely, matrix and inter-membrane space-only (Canet-
Aviles et al., 2004, Junn et al., 2009, Zhang et al., 2005). In order to further investigate 
mitochondrial translocation of DJ-1 following exposure to oxidative stress, and the importance 
of C106 in this process, we wanted to determine the ultrastructural localization pattern of DJ-1 
WT and a C106A mutant using APEX2-fusion proteins. Following detection of DAB staining 
by low magnification light microscopy (Fig. 4.9) SH-SY5Y cells were post-fixed, sectioned 
and stained for transmission electron microscopy and subsequently imaged (Fig 4.10). 
Transfected cells were easily detected by the increased TEM contrast caused by the DAB 
polymer and could be seen as dark colouration throughout the cytoplasm (Fig. 4.10 A, yellow 
frame). In non-transfected cells (Fig 4.10 A, orange frame) only the light background from 
osmium/uranyl staining was visible. 
No difference in staining intensity in the mitochondrial intermembrane space or matrix between 
transfected (Fig. 4.10 B, yellow frame) and non-transfected (Fig. 4.10 B, orange frame) cells 
was observed. The outer membrane did, however, appear darker in transfected cells. Thus, DJ-
1 and the mutant version seem not to be localized in the mitochondria, but possibly associated 





Fig. 4.10 Diaminobenzidine staining in transfected and non-transfected SH-SY5Y cells 
visualized by transmission electron microscopy SH-SY5Y cells were transfected with 
pcDNA3 hDJ-1WT-APEX2-NES and on the following day exposed to 250 nM rotenone for 
24 hours before fixation and diaminobenzidine staining. Samples were subsequently analysed 
by transmission electron microscopy. A: A transfected cell with pronounced DAB staining 
(yellow frame) is shown next to a non-transfected cell with no DAB staining (orange frame). 
The staining is prominent in the cytosol with unstained ER visible as white bands. B: A 
comparison of the mitochondria in the transfected cell in A (yellow border) with those of the 
non-transfected cell in A (orange border). The corresponding areas in A are indicated by a 












4.3.2 DJ-1 induced endoplasmic reticulum-mitochondria contact is unaffected 
by DJ-1 mutation at 106 
The fusion protein plasmids, pcDNA3 Flag-DJ-1WT-APEX2-NES and pcDNA3 Flag-DJ-
1C106A-APEX2-NES, were used to transiently transfect SH-SY5Y cells, and after 24 h the cells 
were treated with 250 nM rotenone or DMSO control. The cells were fixed after 24 h of 
rotenone/DMSO exposure, and subsequently stained with diaminobenzidine, and post-fixed, 
sectioned and stained for transmission electron microscopy (Fig. 4.11). Due to a lack of DAB 
polymerisation in the endoplasmic reticulum, the ER is clearly visible as light bands throughout 
the cytoplasm of transfected cells. An increase in ER-mitochondria contact was seen in all 
transfected samples (Fig. 4.11 A, B, C, D) with ER wrapped closely around the mitochondria 
on these samples. The same interaction was not seen in the non-transfected control (Fig. 4.11 








Fig. 4.11 Overexpression of DJ-1WT and DJ-1C106A increase contact between the 
endoplasmic reticulum and mitochondria. SH-SY5Y cells were transiently transfected 
with pcDNA3 Flag-DJ-1WT-APEX2-NES (A-B) and pcDNA3 Flag-DJ-1C106A-APEX2-NES 
(C-D) or non-transfected as a control (E). 24 hours after transfection cells were exposed to 
250 nM rotenone (B and D) or DMSO as control (A, C and E) for 24 hours. Cells were then 
fixed, stained with diaminobenzidine and imaged by transmission electron microscopy. All 
transfected samples showed increased ER-mitochondria contact with ER appearing as white 
bands coiled around the mitochondria. This increased interaction was not seen in the non-
transfected control sample (E) or in unstained cells within the transfected samples. A scale 




























Since the discovery of DJ-1s role in the cellular defence against oxidative stress and implication 
in both familial and sporadic forms of Parkinson’s disease, much effort has been put into 
understanding the mechanisms and signalling pathways regulated by this protein. In this thesis 
we have examined the importance of the highly conserved and proposed oxidative sensor C106 
residue of DJ-1.  
5.1 Establishment and characterization of the UiB2003 line 
By establishing the UiB2003 zebrafish line (park7-/-,Tg(gfap:egfp-2A-flag-zDJ-1C106A)) and 
comparing it to wild type, and the established DJ-1 KO (park7-/-) and UiB2001 line (park7-/-
,Tg(gfap:egfp-2A-flag-zDJ-1)), we wanted to examine the oxidative stress-mitigating ability of 
DJ-1 and the impact of a C106A mutation on this protective function in vivo.  
The expression pattern of DJ-1C106A in the UiB2003 line was determined by the reporter protein 
eGFP. The insert that is cut out by I-SceI and integrated into the zebrafish genome consists of 
the gene for eGFP and Flag-DJ-1C106A linked by a viral 2A segment. The function of this 2A 
segment is to prevent eGFP from interfering with the activity of DJ-1C106A, as might be the case 
with fused proteins. The 2A viral peptide mediates formation of two separate protein from a 
single transcribed mRNA when it is positioned between two genes (Kim et al., 2011). The two 
proteins are expressed in equimolar amounts as two separate proteins. The successful breaking 
of 2A is easily demonstrated by the fact that Western blots of UiB2003 lysates probed for DJ-
1 (Fig. 4.3) showed the DJ-1C106A band at the expected size of 22 kDa, and not 49 kDa as would 
have been expected of the fused proteins. 
Because both eGFP and DJ-1C106A are transcribed simultaneously under the regulation of the 
same gfap regulatory elements, the expression of eGFP is assumed to correspond to the 
expression pattern of DJ-1C106A. The cellular expression pattern was determined by fluorescence 
microscopy (Fig. 4.2). At 1 dpf positive embryos displayed eGFP expression in the head region 
and along the developing spinal cord. At 2dpf the expression was more distinct, appearing in 
the brain, retina and along the spine of positive larvae. This expression pattern coincides well 
the observations of Bernados and Raymond (Bernardos and Raymond, 2006). They used the 
same GFAP-derived regulatory elements to generate a transgenic zebrafish line with glial 
expression of green fluorescent protein (GFP), Tg(gfap:GFP). At 24 hpf they observed GFP-
expressing cells from the developing brain and along the developing spinal cord, but also in the 




cells of the brain, neural retina, spinal cord and ventral spinal nerves. Our group has previously 
demonstrated gfap reporter driven constructs to be astroglial specific in the zebrafish brain 
(Froyset et al., 2018). 
5.1.1 Transgene inheritance in the UiB2003 line 
The astroglial-restricted DJ-1C106A line, UiB2003, was established using I-SceI meganuclease-
based transgenesis. The resulting F0 fish demonstrated a broad range of germline transmission, 
with 1-50% positive progeny depending on the parent fish outcrossed. This indicates a certain 
degree of mosaicism at the F0 generation, as is expected of the I-SceI system. The germline 
transmission rate cut-off at 50% indicates single insertion events of the transgene and is further 
supported by the Mendelian distribution of the transgene observed at both the F1 generation 
and F2 generation. This is expected as I-SceI-based transgenesis has been shown to favour 
insertion at a single locus. It should be noted that although I-SceI generally leads to a single 
insertion event, this does not guarantee insertion of a single copy of the transgene. It has been 
demonstrated that 1-10 copies in tandem repeat are generally inserted (Grabher et al., 2004). 
Furthermore, as the site of insertion is nonspecific, each F0 fish will have the transgene inserted 
at a different location in the genome, which can in turn affect expression levels further. This 
could partly explain the degree of variation between individuals observed, as individuals could 
have different copy numbers that affects the level of expression and thus their response to 
experimental treatment. Additionally, the UiB2003 F1 generation was not based on a single F0 
founder fish but consists of the combined offspring of multiple outcrossed founders. This is 
expected to result in higher variance than using a single founder fish.  
5.1.2 DJ-1 expression levels in transgenic zebrafish 
The expression level of the DJ-1C106A in the UiB2003 line is more than 10 times higher than 
endogenous DJ-1 levels in astroglia. This is based on the observation that the flag-tagged DJ-
1C106A had higher expression than what was seen for the flag-tagged DJ-1WT of the UiB1001 
line (Fig. 4.3). The astroglial-targeted flag-DJ-1WT of the UiB1001 line is known to be 
expressed at about 10 times the level of the endogenous astroglial DJ-1 (Froyset et al., 2018). 
Due to being under the control of not the natural regulative elements of DJ-1 but those of GFAP, 
the level of expression will be different from endogenous DJ-1. As for the difference in 
expression level between DJ-1C106A in UiB2003 and flag-DJ-1WT of the UiB1001 line, this may 
be due to the mechanism of I-SceI-based transgenesis. While I-SceI generally favours single 
insertion events, it can lead to insertion of low copy number tandem repeats of the gene to be 




in different expression levels. Additionally, because the site of insertion is random, the location 
of the transgene and thus the genomic environment will differ between the lines and between 
individuals, further affecting expression levels (Liu, 2013). The high expression level in the 
UiB2003 line could affect the activity of DJ-1C106A, as this may promote interactions that would 
not occur at endogenous concentrations under basal conditions. It should however be noted that 
DJ-1 has been found to be upregulated in the astrocytes of sporadic PD patients (Bandopadhyay 
et al., 2004). Thus, astrocytic overexpression of DJ-1 may be used to model this PD-
characteristic expression. 
5.1.2 Astroglial-restricted overexpression of DJ-1C106A is non-lethal and without 
phenotype in larvae and young adult zebrafish 
No distinct effect on egg quality or number, development, larval survival or fertility were 
observed in the UiB2003 line under basal conditions. This reflects what has previously been 
observed for the DJ-1 KO line, which does not exhibit a phenotype at this stage (Edson et al., 
2019). An age-related parkinsonian phenotype has however been observed in the DJ-1 KO fish 
aged 1.5-2 years. At this age, some fish may develop a distinct phenotype of low body weight 
and decreased pigmentation. This phenotype is also more common in male fish, possibly 
reflecting the higher tendency of men to develop PD seen in humans (Miller and Cronin-
Golomb, 2010). Neither the UiB2003 line nor the corresponding UiB2001 line have yet reached 
the age where this phenotype occurs in the DJ-1 KO fish. It is therefore still unknown whether 
these lines will develop the same sex-linked phenotype. Either outcome will yield further 
insight into the impact of astroglial-restricted DJ-1 expression as well as the C106A mutation. 
Due to the mosaicism in the F0 generation, any conclusions on the phenotype should not be 
drawn from this generation, as the effect may be due to the fish being partly KO. Any 
conclusions regarding phenotype should initially be made from the heterozygous F1 generation 
where the gene is ubiquitous throughout the body and astroglial expression is uniform. 
Conclusions from the F1 generation could be further validated with comparison to future 
homozygous F2 generations, in case the expression level of DJ-1 plays a role. 
5.1.3 Effect of rotenone-induced oxidative stress on gross larval anatomy 
In the event that the C106A mutation renders DJ-1 completely non-functional, one might have 
expected to see the UiB2003 line respond to oxidative stress in a similar manner as the DJ-1 
KO line. This however, as evident by the results of the rotenone experiments (Fig. 4.5, Fig. 4.6 
and Fig. 4.7) was not the case. Surprisingly, the UiB2003 line performed consistently worse 




experiments (Fig. 4.5). After exposure to rotenone, UiB2003 larvae displayed a significantly 
lower survival rate than both WT and DJ-1 KO larvae, averaging at about 50%, while the 
survival of WT and DJ-1 KO larvae was largely unaffected. Similarly, the propensity to develop 
edema was far higher in treated UiB2003 larvae. As for the rotenone-induced lowering of heart 
rate, this was more severe in UiB2003 compared to the DJ-1 KO. The rotenone dose-response 
experiment also demonstrated a higher sensitivity to rotenone in the UiB2003 line, with the 
entire group having developed edema at the lowest concentration where WT and DJ-1 KO 
larvae appeared completely unaffected (Fig. 4.7). One possible explanation is that DJ-1C106A is 
dysfunctional and unable to exert its protective function, but at the same time perceived by the 
cellular machinery as a functional defence already in action, thereby downregulating or 
delaying alternative protective pathways. In the DJ-1 KO line, no DJ-1 is present and any 
defence must come immediately from the alternative protective pathways leading to faster 
response.  
Interestingly, an effect similar to that seen for UiB2003 was seen in the UiB2001 line. When 
treated with rotenone these larvae had significantly lower survival rate than both the 
corresponding WT and DJ-1 KO group. This may indicate that the lack of protection against 
oxidative stress in astroglial-restricted DJ-1 larvae is independent of the C106 residue. Based 
on the finding that astroglial overexpression of DJ-1WT in the UiB1001 is protective compared 
to endogenous DJ-1 only (Froyset et al., 2018), we initially hypothesised that astroglial 
overexpression of DJ-1WT in larvae with no endogenous DJ-1 could confer some protective 
effect compared to larvae lacking DJ-1 entirely. This is not supported by the findings of this 
thesis. The high astroglial DJ-1WT level may be sufficient to hinder other protective pathways, 
while at the same time unable to compensate for the lack of endogenous DJ-1 throughout the 
body.  This is one of the major difficulties when working with living systems, upregulating a 
single protein can be expected to have a particular effect based on the known pathways it is 
involved in, but may still produce seemingly contradictory results because the complete effects 
of the biological context are not known. 
5.1.4 UiB2003 larvae have altered protein expression both under basal conditions 
and during rotenone-induced oxidative stress 
Following the assessment of gross anatomy and heart rate in response to rotenone-induced 
oxidative stress in the zebrafish larvae. Whole larvae protein lysates were prepared from the 




Analysis of the expression of tyrosine hydroxylase, a marker for dopaminergic cells, in whole 
larvae lysates showed a markedly lower (p<0.01) level in rotenone-treated WT larvae compared 
to WT control larvae (Fig. 4.6). This was expected as rotenone, as well as other parkinsonian 
phenotype-inducing neurotoxicants, have been shown to cause a reduction in TH levels or TH-
positive cells both in vitro and in vivo  (Luo et al., 2007, Marella et al., 2009, Zagoura et al., 
2017). Notably, a similar reduction in TH expression of WT zebrafish larvae has been shown 
in our lab previously using MPP+ (Froyset et al., 2018). In the current study none of the lines 
aside from the WT showed a significant difference in TH levels between treated and untreated 
larvae. One interesting result however, was the markedly lower (p<0.05) TH level found in 
untreated UiB2003 larvae compared to untreated WT. This is in stark contrast to the protective 
effect that has previously been observed with the astroglial DJ-1WT overexpression line, 
UiB1001 (Froyset et al., 2018). Due to the high variation and small sample size of the UiB2001 
larvae groups, which expresses the astroglial-restricted DJ-1WT, it cannot be determined if this 
effect seen in UiB2003 larvae is due to the C106A mutation or if it is related to the fact that 
expression is restricted to astroglia. There were some problems with obtaining eggs from the 
UiB2001 fish, for the experiments, so this should ideally be repeated with larger experimental 
groups. It may be interesting to see if the low TH level in the UiB2003 line under basal 
conditions is specific to the larvae or if this is something that can be observed in the adult fish 
as well. Nevertheless, this seemingly disadvantageous effect of astroglial DJ-1C106A even under 
basal conditions, further supports what was seen for survival, edema and heart rate, that 
astroglial DJ-1C106A has a net negative effect.  
In addition to tyrosine hydroxylase, the effect of rotenone-induced oxidative stress on the 
expression of inducible nitric oxide synthase (iNOS), a marker of intracellular stress, was also 
assessed. Here elevated iNOS levels were observed in rotenone-treated DJ-1 KO larvae 
compared to the treated WT larvae (p<0.05), while the rotenone-treated UiB2003 larvae on the 
other hand expressed significantly less iNOS than the DJ-1 KO (p<0.05). This could indicate a 
protective effect of the astroglial DJ-1C106A despite the mutation. DJ-1 is known to act as a 
negative regulator of iNOS, supressing iNOS induction under conditions of oxidative stress 
(Waak et al., 2009) (see Fig. 1.3). This could explain the significantly higher level of iNOS 
observed in the rotenone-treated DJ-1 KO larvae compared to the wild type. With no DJ-1 
present, the induction of iNOS is not halted through this pathway. Following this, the 
observation that the UiB2003 larvae show significantly lower expression of iNOS could lead 




A counterargument to this idea, however, is the mechanism of iNOS inhibition. This regulation 
is reportedly mediated via direct binding to ASK1, thereby preventing the activating signalling 
pathway from ASK1 via p38/MAPK to iNOS. This binding has been shown to be dependent 
on disulphide-bonding via C106 in DJ-1 and is abolished in DJ-1C106A. The effect on iNOS seen 
in UiB2003 larvae may therefore not be due to the standard inhibition of iNOS induction. 
5.1.5 Mitochondrial complex I activity in the brain, but not in skeletal muscle, is 
rescued by astroglial expression of DJ-1C106A 
Complex I dysregulation has been linked to the pathogenesis of PD, as both the activity and 
amount of complex I has been found to be reduced in post-mortem substantia nigra of PD 
patients (Schapira et al., 1990). 
Previous results from studying the DJ-1 KO zebrafish line in our lab have shown a DJ-1 
dependent effect on both the expression level of mitochondrial complex I components and on 
the activity of the complex (Edson et al., 2019). A complex I activity assay performed using 
protein lysates from WT and DJ-1 KO adult fish showed reduced complex I activity in the DJ-
1 KO both in skeletal muscle (Edson et al., 2019) and in brain compared to the WT reference 
(Elda, unpublished data). We then wanted to investigate if astroglial DJ-1C106A in UiB2003 fish 
would rescue this drop in complex I activity. While DJ-1 has been shown to be involved in the 
regulation of mitochondrial complex I activity, little is known about the role of cysteine 106 in 
this regulation (Hayashi et al., 2009). By comparing samples of astroglia-rich brain with skeletal 
muscle, which does not contain astroglia, the effect of DJ-1C106A vas examined. As seen in 
figure 4.8, the C106A mutant form of DJ-1 appears to retain some of its function. Complex I 
activity remained unaffected compared to WT in brain samples but was reduced in skeletal 
muscle tissue. This tissue-specific effect is likely due to the lack of astroglia in skeletal muscle 
and high number in brain. Thus, C106 does not appear to be critical for the complex I-regulating 
activity of DJ-1. 
5.2 hDJ-1WT/C106A-APEX2 fusion protein-based protein localization 
The C106 residue has been proposed to be an oxidative stress sensor which upon oxidation 
enables DJ-1 to translocate to the mitochondria (Junn et al., 2009, Canet-Aviles et al., 2004). 
Conflicting results have been shown as to where DJ-1 localizes in the mitochondria and to what 
degree the C106 is involved (Canet-Aviles et al., 2004, Junn et al., 2009, Cali et al., 2015). To 
further investigate the role of C106 we utilized the newly developed APEX2-based method 




can be used to determine intracellular localization and protein-protein interaction (Lam et al., 
2015, Martell et al., 2017, Hung et al., 2016). 
5.2.1 Considerations for the fusion of APEX2 to DJ-1 
One major point of concern when designing the DJ-1WT/C106A-APEX2 constructs was the 
possibility of APEX2-fusion to DJ-1 altering the activity of DJ-1. DJ-1 is a relatively small 
protein at only ca. 20 kDa. Linking it to APEX2, a 27 kDa protein could therefore perturb its 
endogenous function and localization. This is one of the main concerns with using the APEX2 
method for ultrastructural localization.  
It has been proposed that the N-terminal sequence of DJ-1 is needed for the protein to 
translocate to the mitochondria (Maita et al., 2013). The attachment of an N-terminal Flag tag 
or the deletion of the N-terminal most 12 amino acids led to altered localization of both wild 
type and some mutant forms of DJ-1, to mainly cytosolic. The change in wild type DJ-1 
localization was not dramatic. It should, however, be noted that this was under basal conditions 
and not under elevated oxidative stress. Due to the possible involvement of the N-terminal end 
in localization, we decided to fuse APEX2 to the C-terminal ends of DJ-1WT and DJ-1C106A 
respectively. 
One particular concern was whether APEX2-linking would interfere with DJ-1 dimerization. 
The importance of dimerization for DJ-1 to exert its functions has been demonstrated by mutant 
forms of the protein. One of the first two DJ-1 mutations found to cause familial PD, the loss-
of function L166P mutation, was later discovered to impair the formation of DJ-1 homodimers, 
as did multiple other PD causative mutations (M26I, L10P, and P158∆) (Repici et al., 2013). It 
is therefore believed that formation of homodimers is integral in the normal function of DJ-1 
and that inability to dimerize is the main reason these mutations are detrimental. Both termini 
of APEX2 are positioned at the surface of the protein and based on crystal structures, the C-
terminal ends of DJ-1 appear to protrude from the surface of the DJ-1 dimer as well. To reduce 
the risk of steric interference, DJ-1 and APEX2 were not fused directly but connected by a 
flexible linker region. Furthermore, it has previously been shown in our lab that fusing DJ-1 to 
green fluorescent protein does not prevent dimerization of DJ-1 (Fladmark, unpublished data). 
As GFP and APEX2 are the same size and both have globular shapes, this would suggest that 




5.2.2 Ultrastructural localization of APEX2-fused DJ-1 WT and mutant form 
The cellular localization of DJ-1 was initially determined by fractionation and fluorescence 
analysis of EGFP-linked DJ-1 and found to be largely cytoplasmic with a smaller pool of DJ-1 
inhabiting the nucleus (Nagakubo et al., 1997). Since then, multiple studies have proposed a 
mitochondria-localized pool of DJ-1 as well, possibly dependent on the oxidative state of the 
cell. This is however disputed. One study found endogenous DJ-1 in mouse cell cultures to not 
colocalize with mitochondrial marker under basal conditions at all (Bandopadhyay et al., 2004). 
Conversely, Zhang et al. found 25% of DJ-1 to localize to the mitochondria in SH-SY5Y cells 
based on subcellular fractionation, independent of treatment with a PD model neurotoxicant 
(paraquat) (Zhang et al., 2005). Yet another study, based on a split-GPF-based approach, found 
the translocation of DJ-1WT to be dependent on oxidative stress induced by rotenone or H2O2, 
or on nutrient depletion, and a C106T mutant unable to translocate (Cali et al., 2015). Junn et 
al. found 8-10% of DJ-1WT and DJ-1C106S to translocate to the mitochondria, but only following 
exposure to oxidative stress (H2O2), suggesting that oxidative stress, but not cysteine 106, is 
essential for translocation (Junn et al., 2009). Canet-Avilés et al, on the other hand, while also 
deeming oxidative stress essential for translocation, found the C106 to be essential and 
translocation to be abrogated in DJ-1C106A. Opinions on the sub-mitochondrial localization of 
DJ-1 is also conflicting, with outer membrane (OMM)-only, inter membrane space and matrix-
restricted, or matrix has been proposed (Canet-Aviles et al., 2004, Junn et al., 2009, Cali et al., 
2015). 
At the high mitochondrial DJ-1 levels proposed by Zhang et al. and Junn et al. (Junn et al., 
2009, Zhang et al., 2005), mitochondrial DJ-1 staining, and particularly interior staining, should 
be easily identified in the TEM images using the APEX2-based method, but no such strong 
staining is observed when transfecting our APEX2 constructs into the neuroblastoma cell line 
SH-SY5Y (Fig. 4.10). There was no observable localization to the mitochondrial inter-
membrane space or matrix in rotenone-treated SH-SY5Y cells expressing DJ-1WT-APEX2. 
Possibly some stronger staining on the outer mitochondrial membrane compared to the inner 
membrane could be seen, but to determine this would require a more thorough densiometric 
analysis across the mitochondrial membranes, and preferably by comparing the OMM to MIM 
staining intensity ratio of APEX2-DJ-1-transfected cells with the ratio in APEX2-NES-
transfected cells, as this would provide a more similar cytosolic background stain.  
As stated in section 5.2.1, there is of course the possibility of APEX2 fusion interfering with 




mutants to readily translocate to the mitochondria, but whether the monomeric form is needed 
for translocation to occur with DJ-1WT is not known (Maita et al., 2013). If the monomeric form 
is needed due to a size constraint in the process facilitating transport across the OMM and/or 
MIM, fusion with APEX2 would likely interfere. 
5.2.3 DJ-1 and effect on ER-mitochondria association 
During the TEM-based visualisation of DJ-1 localization, we noticed a change in the 
organisation of organelles in transfected vs. non-transfected cells. APEX2-DJ-1-overexpressing 
cells displayed a pronounced increase in the contact between the mitochondria and endoplasmic 
reticulum (Fig. 4.11). This effect of APEX2-DJ-1 overexpression was independent both of 
C106 and rotenone induced oxidative stress. 
Dysregulation of mitochondrial function has long been implicated in neurodegenerative 
disorders. More recently, attention has been brought to the role of mitochondria-associated ER 
membranes (MAMs), specialised ER subdomains that act as contact sites linking the ER and 
mitochondrial networks. MAMs have several functions including lipid synthesis, calcium 
signalling and uptake in the mitochondria, bioenergetics, and apoptosis, and there is now 
emerging evidence that dysregulation of these MAMs play a role in neurodegenerative 
disorders, including Parkinson’s disease (Liu and Zhu, 2017, Paillusson et al., 2016). 
Overexpression of DJ-1 has previously been shown to promote an increase in the contact 
between endoplasmic reticulum and mitochondria, indicating a regulatory role in MAMs 
(Ottolini et al., 2013). Thus, our study supports this and does also suggest that the effect on 















Astroglial-restricted expression of DJ-1C106A does not protect zebrafish larvae from rotenone-
induced insult and in fact proved more detrimental than a complete lack of DJ-1, with lower 
survival, high edema incidence and lowered heartrate, as well as higher sensitivity to low doses 
of rotenone. At the protein level, astroglial-restricted expression of DJ-1C106A led to altered 
iNOS and TH expression compared to that seen in WT and DJ-1 KO groups, both under basal 
conditions and during oxidative stress. 
DJ-1 does not appear to enter the intermembrane space or matrix of mitochondria in SH-SY5Y 
cells, independent of cysteine 106 and exposure to oxidative stress. Localization to the outer 
mitochondrial membrane is a possibility but requires further investigation. Overexpression of 
DJ-1 was however found to induce increased ER-mitochondria contact in a C106 independent 
manner. 
DJ-1C106A appears to be partly functional, retaining some activities that are lost in KO systems 


















7 Future perspectives 
As previously mentioned in section 5.1.2, the DJ-1 KO fish have been shown to develop an 
age-related parkinsonian phenotype, where the fish, and especially the males, have lower body 
weight and become pale at 1.5-2 years of age. It would be interesting to see in the future whether 
UiB2001 and UiB2003 fish develop a similar phenotype. 
The UiB2001 and UiB2003 lines provide a means to further examine the effect of DJ-1 
overexpression on the astroglial protein profile of zebrafish, free of the endogenous 
background. This may lead to greater insight into the role of the C106 residue, as the lines can 
be compared and differences in protein regulation determined. This could also validate the 
results found for DJ-1’s effect on complex I activity in the adult zebrafish, as you could 
determine if the upregulation of complex I components seen in the DJ-1 KO line (Edson et al., 
2019) is missing in the UiB2001 and UiB2003 lines. Considering that both UiB2001 and 
UiB2003 fish have astroglial-restricted expression of eGFP, one could do FACS-based cell 
sorting followed by astroglial-specific protein mapping to identify effects of C106 on the 
astroglial proteome. 
The effect of on mitochondrial functions such as complex I activity may be further examined 
by Seahorse XF-based metabolic studies, either on whole larvae or on extracted mitochondria.  
The protective function of DJ-1 is proposed to act via the Nrf2/ARE pathway and to be 
dependent on functional DJ-1 C106 oxidation (Edson et al., 2019, Moscovitz et al., 2015). We 
have newly obtained a Nrf2 activity reporter construct that could be used in combination with 
the UiB2001 and UiB2003 lines to examine the involvement of Nrf2 activation. If there is a 
C106-dependent difference in Nrf2 activation in response to oxidative stress, this could be 
quantified. Is the reduced protection from rotenone-induced insult, that was observed in the 
UiB2003 line, due to impaired Nrf2 activation? 
We were not able to determine whether DJ-1 localizes with the OMM, as has been proposed in 
multiple studies. One way to further examine this would be to determine localization using 
APEX2-NES-expressing cells as reference. This could make densiometric analysis of DAB 
staining across the mitochondrial outer and inner membrane easier, as it would give a similar 
background staining. There was a possible difference in staining intensity of the outer and inner 
mitochondrial membrane of transfected cells, but this proved difficult to quantify due to the 




Proximity-based protein mapping (see section 1.6) with the APEX2 constructs could be used to 
compare the DJ-1WT and the DJ-1C106A interactome, and especially proteins linked to oxidative 
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